Document:

EX-4.2

$125,000,000 AGGREGATE PRINCIPAL AMOUNT

ALASKA COMMUNICATIONS SYSTEMS GROUP, INC.

5.75% CONVERTIBLE NOTES

DUE 2013

Resale Registration Rights Agreement

dated April 8, 2008

1

RESALE REGISTRATION RIGHTS AGREEMENT, dated as of April 8, 2008, among Alaska
Communications Systems Group, Inc., a Delaware corporation (together with any successor entity,
herein referred to as the “Company”), the guarantors of the Notes (the “Guarantors”) named in the
Purchase Agreement (as defined below), Banc of America Securities LLC and Oppenheimer & Co. Inc as
initial purchasers (the “Initial Purchasers”) under the Purchase Agreement (as defined below).

Pursuant to the Purchase Agreement, dated as of April 2, 2008, among the Company, the
Guarantors and the Representatives (the “Purchase Agreement”), relating to the initial placement
(the “Initial Placement”) of the Notes (as defined below), the Initial Purchasers have agreed to
purchase from the Company $125,000,000 in aggregate principal amount of 5.75% Convertible Notes due
2013 (the “Notes”). The Notes will be convertible, subject to the terms thereof, into fully paid,
nonassessable shares of common stock, par value $0.01 per share, of the Company (the “Common
Stock”). To induce the Initial Purchasers to purchase the Notes, the Company has agreed to provide
the registration rights set forth in this Agreement pursuant to Section 5(g) of the Purchase
Agreement.

The parties hereby agree as follows:

1. Definitions. Capitalized terms used in this Agreement without definition shall have their
respective meanings set forth in the Purchase Agreement. As used in this Agreement, the following
capitalized terms shall have the following meanings:

“Additional Interest”: As defined in Section 3(a) hereof.

“Additional Interest Payment Date”: Each March 1 and September 1.

“Affiliate” of any specified person means any other person which, directly or indirectly, is
in control of, is controlled by, or is under common control with, such specified person. For
purposes of this definition, control of a person means the power, direct or indirect, to direct or
cause the direction of the management and policies of such person whether by contract or otherwise;
and the terms “controlling” and “controlled” have meanings correlative to the foregoing.

“Agreement”: This Resale Registration Rights Agreement.

“Amendment Effectiveness Deadline Date”: As defined in Section 2(f) hereof.

“Blue Sky Application”: As defined in Section 6(a)(i) hereof.

“Business Day”: The definition of “Business Day” in the Indenture.

“Closing Date”: The date of the first issuance of the Notes.

“Commission”: Securities and Exchange Commission.

“Common Stock”: As defined in the preamble hereto.

“Company”: As defined in the preamble hereto.

“DTC”: The Depository Trust Company.

“Effectiveness Date”: As defined in Section 2(a)(iii) hereof.

“Effectiveness Period”: As defined in Section 2(a)(iv) hereof.

“Effectiveness Target Date”: As defined in Section 2(a)(ii) hereof.

“Exchange Act”: Securities Exchange Act of 1934, as amended.

“FINRA”: Financial Industry Regulatory Authority, Inc.

“Free Writing Prospectus”: A free writing prospectus, as defined in Rule 405 under the
Securities Act.

“Guarantors”: As defined in the preamble hereto.

“Holder”: A Person who owns, beneficially or otherwise, Transfer Restricted Securities.

“Indemnified Holder”: As defined in Section 6(a) hereof.

“Indenture”: The Indenture, dated as of April 8, 2008, among the Company, the Guarantors and
The Bank of New York Trust Company, N.A., as trustee (the “Trustee”), pursuant to which the
Securities are to be issued, as such Indenture is amended, modified or supplemented from time to
time in accordance with the terms thereof.

“Initial Placement”: As defined in the preamble hereto.

“Initial Purchasers”: As defined in the preamble hereto.

“Issuer Free Writing Prospectus”: An issuer free writing prospectus, as defined in Rule 433
under the Securities Act.

“Losses”: As defined in Section 6(a) hereof.

“Majority of Holders”: Holders holding over 50% of the aggregate principal amount of Notes
outstanding; provided that for the purpose of this Agreement, a holder of shares of Common Stock
which constitute Transfer Restricted Securities shall be deemed to hold an aggregate principal
amount of the Notes (in addition to the principal amount of the Notes held by such holder) equal to
the quotient of (x) the number of such shares of Common Stock that are Transfer Restricted
Securities held by such holder and (y) the conversion rate in effect at the time of their issuance
upon conversion of the Notes as determined in accordance with the Indenture.

“Managing Underwriter”: The investment banker or investment bankers and manager or managers
that administer an underwritten offering, if any, conducted pursuant to Section 8 hereof.

“Notes”: As defined in the preamble hereto.

“Notice and Questionnaire” means a written notice executed by the applicable Holder and
delivered to the Company containing substantially the information called for by the Selling
Securityholder Notice and Questionnaire attached as Appendix A to the Offering Memorandum of the
Company relating to the Notes.

“Notice Holder”: On any date, any Holder of Transfer Restricted Securities that has delivered
a Notice and Questionnaire to the Company on or prior to such date.

“Permitted Free Writing Prospectus”: As defined in Section 9(a) hereof.

“Person”: An individual, partnership, corporation, company, unincorporated organization,
trust, joint venture or a government or agency or political subdivision thereof.

“Purchase Agreement”: As defined in the preamble hereto.

“Prospectus”: The prospectus included in a Shelf Registration Statement, as amended or
supplemented by any prospectus supplement and by all other amendments thereto, including
post-effective amendments, and all material incorporated by reference into such prospectus.

“Record Holder”: With respect to any Additional Interest Payment Date, each Person who is a
registered holder of the Notes on the 15th day of the month preceding the relevant
Additional Interest Payment Date.

“Registration Default”: As defined in Section 3(a) hereof.

“Representatives”: As defined in the preamble hereto.

“Rule 144,” “Rule 144A,” “Rule 405,” “Rule 415,” “Rule 424,” “Rule 433,” “Rule 430A,” “Rule
430B,” “Rule 430C”: In each case, such rule as promulgated under the Securities Act.

“Securities”: The Notes and the Shares.

“Securities Act”: Securities Act of 1933, as amended.

“Shares”: the shares of Common Stock into which the Notes are convertible or that have been
issued upon any conversion of Notes into Common Stock.

“Shelf Filing Deadline”: As defined in Section 2(a)(i) hereof.

“Shelf Registration Statement”: The shelf registration statement referred to in Section
2(a)(ii), as amended or supplemented by any amendment or supplement, including post-effective
amendments and any additional information contained in a form of prospectus supplement that is
deemed retroactively to be a part of the Shelf Registration Statement pursuant to Rules 430A, 430B
or 430C, and all materials incorporated by reference or explicitly deemed to be incorporated by
reference in such Shelf Registration Statement.

“Suspension Notice”: As defined in Section 4(c) hereof.

“Suspension Period”: As defined in Section 4(b)(ii) hereof.

“TIA”: Trust Indenture Act of 1939, as amended, and the rules and regulations of the
Commission thereunder, in each case, as in effect on the date the Indenture is qualified under the
TIA.

“Transfer Restricted Securities”: Each Note and each share of Common Stock issued upon
conversion of Notes until the earliest of:

(i) the date on which such Note or such share of Common Stock issued upon
conversion has been effectively registered under the Securities Act and disposed of
in accordance with the Shelf Registration Statement;

(ii) the first date after (i) April 8, 2009 or (ii) if the notes are reopened,
the one-year anniversary of the last original issue date of such reopening, on which
the Securities are freely transferable without restrictions by Holders that are not
Affiliates of the Company in compliance with Rule 144 (or any other similar
provision then in force);

(iii) the date on which such Note or such share of Common Stock issued upon
conversion ceases to be outstanding (whether as a result of redemption, repurchase
and cancellation, conversion or otherwise); or

(iv) the date on which such Note or such share of Common Stock has otherwise
been transferred and a new Note or share of Common Stock not subject to transfer
restrictions under the Securities Act has been delivered by or on behalf of the
Company in accordance with the Indenture.

“underwriter”: Any underwriter of Transfer Restricted Securities in connection with an
offering thereof under the Shelf Registration Statement.

“Underwritten Registration”: A registration in which Transfer Restricted Securities of the
Company are sold to an underwriter for reoffering to the public.

Unless the context otherwise requires, the singular includes the plural, and words in the
plural include the singular.

2. Shelf Registration.

(a) At any time after April 8, 2009, if any Securities are not freely transferable
without restrictions by Holders that are not Affiliates of the Company in compliance with
Rule 144 (or any other similar provision then in force) (such date, the “Effectiveness
Target Date”), the Company shall:

(i) promptly notify all Holders that the Securities are not then freely
transferable;

(ii) use commercially reasonable efforts to cause to be filed a Shelf
Registration Statement pursuant to Rule 415 or any similar rule that may be adopted
by the Commission for the registration of, and the sale on a continuous or delayed
basis by the Holders of, all of the Transfer Restricted Securities;

(iii) use commercially reasonable efforts to cause the Shelf Registration
Statement to be declared effective under the Securities Act, or otherwise make
available for use by Holders a previously filed effective Shelf Registration
Statement, on the Effectiveness Target Date (the date of such effectiveness or
availability, the “Effectiveness Date”); and

(iv) use commercially reasonable efforts to keep the Shelf Registration
Statement continuously effective, supplemented and amended as required by the
Securities Act and by the provisions of Section 4(b) hereof to the extent necessary
to ensure that it is available for resales by the Holders entitled, subject to the
terms and conditions hereof, to the benefit of this Agreement until the earliest of
(A) such date that the Securities covered by such Shelf Registration cease to be
Transfer Restricted Securities and (B) the date by which all Transfer Restricted
Securities have been sold pursuant to such Shelf Registration Statement (the
“Effectiveness Period”). Notwithstanding any provision of this Agreement to the
contrary, under no circumstances shall there be a Registration Default, in respect
of any period following April 8, 2009, when the Securities are freely transferable
without restrictions by Holders that are not Affiliates of the Company in
compliance with Rule 144 (or any other similar provision then in force).

(v) The Company shall be deemed not have used commercially reasonable efforts
to keep the Shelf Registration Statement effective during the Effectiveness Period
if it voluntarily takes any action that would result in Holders not being able to
offer and sell such securities at any time during the Effectiveness Period, unless
such action is (x) required by applicable law or otherwise undertaken by the Company
in good faith and for valid business reasons (not including avoidance of the
Company’s obligations hereunder), including the acquisition or divestiture of
assets, or (y) permitted by Section 4(b)(ii) hereof.

(b) Promptly upon any determination by the Company that it will be required to file a
Shelf Registration Statement but no later than the Effectiveness Target Date, the Company
shall notify the Holders of such obligation and will mail the Notice and Questionnaire to
any Holder who then so requests a copy. The Company will name each Holder that becomes a
Notice Holder prior to the 20th Business Day before the Effectiveness Date of a
Shelf Registration Statement, if one is required to be filed, as a selling securityholder in
the Shelf Registration Statement at the Effectiveness Date. In any event, the Company will
use commercially reasonable efforts to, within 20 Business Days of a Holder becoming a
Notice Holder, file any amendments to the Shelf Registration Statement or supplements to the
related Prospectus as are necessary to name the Holder as a selling securityholder in the
Prospectus; provided that the Company shall not be required to file more than one
post-effective amendment in any calendar quarter.

(c) If the Shelf Registration Statement ceases to be effective for any reason at any
time during the Effectiveness Period (other than because all Transfer Restricted Securities
registered thereunder shall have been resold pursuant thereto or shall have otherwise ceased
to be Transfer Restricted Securities), the Company shall use commercially reasonable efforts
to obtain the prompt withdrawal of any order suspending the effectiveness thereof or file or
designate a subsequent Shelf Registration Statement covering all of the securities that as
of the date of such filing or designation are Transfer Restricted Securities. If such a
subsequent Shelf Registration Statement is filed or designated (and is not already
effective), the Company shall use commercially reasonable efforts to cause the subsequent
Shelf Registration Statement to become effective as promptly as is practicable after such
filing or designation and to keep such subsequent Shelf Registration Statement continuously
effective until the end of the Effectiveness Period.

(d) The Company shall supplement and amend the Shelf Registration Statement if required
by the rules, regulations or instructions applicable to the registration form used by the
Company for such Shelf Registration Statement, if required by the Securities Act or as
reasonably requested by the Initial Purchasers or by the Trustee on behalf of the Holders of
the Transfer Restricted Securities covered by such Shelf Registration Statement.

(e) The Company shall cause the Shelf Registration Statement and the related Prospectus
and any amendment or supplement thereto, as of the effective date of the Shelf Registration
Statement or such amendment or supplement, and any Issuer Free Writing Prospectus, as of the
date thereof, (i) to comply in all material respects with the applicable requirements of the
Securities Act, and (ii) not to contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the
statements therein (in the case of the Prospectus and any Issuer Free Writing Prospectus, in
light of the circumstances under which they were made) not misleading.

(f) Each Holder agrees that if such Holder wishes to sell Transfer Restricted
Securities pursuant to a Shelf Registration Statement and related Prospectus, it will do so
only in accordance with the terms and conditions of this Agreement. Each Holder wishing to
sell Transfer Restricted Securities pursuant to a Shelf Registration Statement and related
Prospectus from and after the Effectiveness Date agrees to deliver a Notice and
Questionnaire to the Company within 20 Business Days after receipt of the Notice and
Questionnaire. From and after the Effectiveness Date, the Company shall, as promptly as
practicable but in no event later than (x) 20 Business Days after the date delivery it of
the Notice and Questionnaire (but no earlier than 20 Business Days after effectiveness) and
(y) 20 Business Days after the expiration of any Suspension Period in effect when the Notice
and Questionnaire is delivered or put into effect within 20 Business Days of such delivery
date, use commercially reasonable efforts to:

(i) if required by applicable law, file with the SEC a post-effective amendment
to the Shelf Registration Statement or prepare and, if required by applicable law,
file a supplement to the related Prospectus or a supplement or amendment to any
document incorporated therein by reference or file any other required document so
that the Holder delivering such Notice and Questionnaire is named as a selling
securityholder in the Shelf Registration Statement and the related Prospectus in
such a manner as to permit such Holder to deliver such Prospectus to purchasers of
the Transfer Restricted Securities in accordance with applicable law and, if the
Company shall file a post-effective amendment to the Shelf Registration Statement,
use its best effort to cause such post-effective amendment to become effective under
the Securities Act as promptly as is practicable, but in any event by the date that
is 45 days after the date such post-effective amendment is required by this clause
to be filed (the “Amendment Effectiveness Deadline Date”);

(ii) provide such Holder copies of the any documents filed pursuant to Section
2(f)(i); and

(iii) notify such Holder as promptly as practicable after the effectiveness
under the Securities Act of any post-effective amendment filed pursuant to Section
2(f)(i);

provided that if such Notice and Questionnaire is delivered during a Suspension Period, the Company
shall so inform the Holder delivering such Notice and Questionnaire and shall take the actions set
forth in clauses (i), (ii) and (iii) above upon expiration of the Suspension Period in accordance
with Section 4(b); and provided, further, that the Company shall not be required to file more than
one post-effective amendment in any calendar quarter. Notwithstanding anything contained herein to
the contrary, (i) the Company shall be under no obligation to name any Holder that is not a Notice
Holder as a selling securityholder in any Shelf Registration Statement or related Prospectus and
(ii) the Amendment Effectiveness Deadline Date shall be extended by up to 10 Business Days from the
Expiration of a Suspension Period (and the Company shall incur no obligation to pay Additional
Interest during such extension) if such Suspension Period shall be in effect on the Amendment
Effectiveness Deadline Date.

(g) Promptly, on the first date after (i) April 8, 2009 or (ii) if the notes are
reopened, the one-year anniversary of the last original issuance date of such reopening, on
which the Securities are freely transferable without restrictions by Holders that are not
Affiliates of the Company in compliance with Rule 144 (or any other similar provision then
in force), the Company shall notify the Trustee to remove any restrictive legends from such
Securities (and upon such notice the restrictive legends shall be deemed removed; notify
the Holders that the restrictive legends have been removed or deemed removed; and notify the
Trustee and DTC to change the CUSIP number for the Securities to the unrestricted CUSIP
number.

3. Additional Interest.

(a) If:

(i) the Shelf Registration Statement has not been filed with and declared
effective by the Commission, or a previously effective Shelf Registration Statement
has not been made available, prior to or on the Effectiveness Target Date;

(ii) the Company has failed to perform its obligations set forth in Section
2(f) within the time periods required therein;

(iii) any post-effective amendment to a Shelf Registration Statement filed
pursuant to Section 2(f)(i) has not become effective under the Securities Act on or
prior to the Amendment Effectiveness Deadline Date;

(iv) except as provided in Section 4(b)(ii) hereof, the Shelf Registration
Statement is filed and has become effective but, during the Effectiveness Period,
thereafter ceases to be effective or fails to be usable for its intended purpose for
more than 5 Business Days (including, without limitation, because the Notice and
Questionnaire were not received by any Holders more than 20 days prior to the
commencement of the Effectiveness Period);

(v) Suspension Periods exceed an aggregate of 30 days within any 90-day period
or an aggregate of 90 days in any 360-day period; or

(vi) by the one year anniversary of the last date of issuance of the Notes, the
Company has failed to remove the restrictive legends from the Securities relating to
the Securities Act;

(each such event referred to in foregoing clauses (i) through (vi), a “Registration
Default”), the Company hereby agrees to pay interest (“Additional Interest”) with respect to
the Transfer Restricted Securities from and including the day following the Registration
Default to but excluding the earlier of (1) the day on which the Registration Default has
been cured and (2) the date the Shelf Registration Statement is no longer required to be
kept effective, accruing at a rate:

(A) in respect of the Notes, to each Holder of Notes, equal to 0.50%
per annum of the aggregate principal amount of the Notes; provided that in
no event shall Additional Interest, when taken together with Supplementary
Interest (as defined in the Indenture) that the Company shall have paid in
accordance with the provisions of the Indenture, accrue at a rate per year
exceeding 0.50% of the aggregate principal amount of the Notes; and

(B) in respect of the Notes that are Transfer Restricted Securities
submitted for conversion into Common Stock during the existence of a
Registration Default with respect to the Common Stock, the Holder will not
be entitled to receive any Additional Interest with respect to such Common
Stock other than to the extent specified in the Indenture; and

(C) in respect of Common Stock issued upon conversion of Notes, each
Holder of such Common Stock will not be entitled to any Additional Interest
if the Registration Default with respect to such Common Stock occurs after
the Holder has converted the Notes into Common Stock.

(b) All accrued Additional Interest shall be paid in arrears to Record Holders by the
Company on each Additional Interest Payment Date. Upon the cure of all Registration
Defaults relating to any particular Transfer Restricted Security, the accrual of applicable
Additional Interest will cease.

All obligations of the Company set forth in this Section 3 that are outstanding with respect
to any Transfer Restricted Security at the time such security ceases to be a Transfer Restricted
Security shall survive until such time as all such obligations with respect to such Transfer
Restricted Security shall have been satisfied in full.

The Company shall notify the Trustee promptly upon the happening of each and every
Registration Default. The Trustee shall be entitled, on behalf of Holders, to seek any available
remedy for the enforcement of this Agreement, including for the payment of any Additional Interest
if any becomes due. The Additional Interest set forth above shall be the exclusive monetary remedy
available to the Holders of Transfer Restricted Securities for each Registration Default. Nothing
shall preclude a Notice Holder or Holder from pursuing or obtaining specific performance or other
equitable relief with respect to this Agreement.

4. Registration Procedures.

(a) In connection with the Shelf Registration Statement, the Company shall comply with
all the provisions of Section 4(b) hereof and shall use commercially reasonable efforts to
effect such registration to permit the sale of the Transfer Restricted Securities, and
pursuant thereto, shall as expeditiously as possible prepare and file with the Commission a
Shelf Registration Statement relating to the registration on any appropriate form under the
Securities Act, or otherwise make available for use by Holders a previously filed Shelf
Registration Statement.

(b) In connection with the Shelf Registration Statement and any Prospectus required by
this Agreement to permit the sale or resale of Transfer Restricted Securities, the Company
shall:

(i) Subject to any notice by the Company in accordance with this Section 4(b)
of the existence of any fact or event of the kind described in Section 4(b)(iv)(D),
use commercially reasonable efforts to keep the Shelf Registration Statement
continuously effective during the Effectiveness Period; upon the occurrence of any
event that would cause the Shelf Registration Statement or the Prospectus contained
therein (A) to contain a material misstatement or omission or (B) not to be
effective and usable for resale of Transfer Restricted Securities during the
Effectiveness Period, the Company shall file promptly a post-effective amendment to
the Shelf Registration Statement or an amendment or supplement to the related
Prospectus or file any other required document, in the case of clause (A),
correcting any such misstatement or omission, and, in the case of either clause (A)
or (B), use commercially reasonable efforts to cause any such amendment to become
effective and the Shelf Registration Statement and the related Prospectus to become
usable for their intended purposes as soon as practicable thereafter.

(ii) Notwithstanding Section 4(b)(i) hereof, the Company may suspend the
effectiveness of the Shelf Registration Statement if:

(A) an event occurs and is continuing as a result of which the Shelf
Registration Statement, the Prospectus, any amendment or supplement thereto, or any
document incorporated by reference therein would, in the Company’s judgment,
contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading or if an event set forth in Section 4(b)(iv)(C) occurs; and

(B) the disclosure relates to a previously undisclosed proposed or pending
material business transaction, the disclosure of which the Company determines in
good faith would be reasonably likely to impede the Company’s ability to consummate
such transaction, or in respect of any other material event, the Company determines
in good faith that the disclosure of a material event at such time would be
detrimental to the Company and its subsidiaries.

Upon the occurrence of any event described in clauses (A) and (B) of this Section 4(b)(ii),
the Company shall give notice to the Holders that the availability of the Shelf Registration
is suspended and, upon actual receipt of any such notice, each Holder agrees not to sell any
Transfer Restricted Securities pursuant to the Shelf Registration until such Holder’s
receipt of copies of the supplemented or amended Prospectus provided for in Section 4(b)
hereof. The period during which the availability of the Shelf Registration and any
Prospectus is suspended (the “Suspension Period”) shall not exceed 30 days in any 90-day
period; provided that Suspension Periods shall not exceed an aggregate of 90 days in any
360-day period. The Company shall not be required to specify in the written notice to the
Holders the nature of the event giving rise to the Suspension Period.

(iii) Prepare and file with the Commission such amendments and post-effective
amendments to the Shelf Registration Statement as may be necessary to keep the Shelf
Registration Statement effective during the Effectiveness Period; cause the
Prospectus to be supplemented by any required Prospectus supplement, and as so
supplemented to be filed pursuant to Rule 424, and to comply fully with the
applicable provisions of Rule 424 in a timely manner; and comply with the provisions
of the Securities Act with respect to the disposition of all Transfer Restricted
Securities covered by the Shelf Registration Statement during the applicable period
in accordance with the intended method or methods of distribution by the sellers
thereof set forth or to be set forth in the Shelf Registration Statement or
supplement to the Prospectus.

(iv) Advise the selling Holders and any Initial Purchaser that has provided in
writing to the Company a telephone or facsimile number and address for notices,
promptly and, if requested by such selling Holders, to confirm such advice in
writing (which notice pursuant to clauses (B) through (E) below shall be accompanied
by an instruction to suspend the use of the Prospectus until the Company shall have
remedied the basis for such suspension):

(A) when the Prospectus, any Prospectus supplement, any post-effective
amendment or any Issuer Free Writing Prospectus has been filed, and, with
respect to the Shelf Registration Statement or any post-effective amendment
thereto, when the same has become effective,

(B) of any request by the Commission for amendments or supplements to
the Shelf Registration Statement, the Prospectus or any Issuer Free Writing
Prospectus or for additional information relating thereto,

(C) of the issuance by the Commission of any stop order suspending the
effectiveness of the Shelf Registration Statement under the Securities Act
or of any notice that would prevent its use, or of the suspension by any
state securities commission of the qualification of the Transfer Restricted
Securities for offering or sale in any jurisdiction, or the threatening or
initiation of any proceeding for any of the preceding purposes,

(D) of the existence of any fact or the happening of any event, during
the Effectiveness Period, that makes any statement of a material fact made
in the Shelf Registration Statement, the Prospectus, any amendment or
supplement thereto, or any document incorporated by reference therein
untrue, or that requires the making of any additions to or changes in the
Shelf Registration Statement or the Prospectus in order to make the
statements therein (in the case of the Prospectus, in the light of the
circumstances under which they were made) not misleading, or

(E) when any Issuer Free Writing Prospectus includes information that
may conflict with the information contained in the Registration Statement.

(iv) If at any time the Commission shall issue any stop order suspending the
effectiveness of the Shelf Registration Statement or any notice that would prevent
its use, or any state securities commission or other regulatory authority shall
issue an order suspending the qualification or exemption from qualification of the
Transfer Restricted Securities under state securities or Blue Sky laws, the Company
shall use commercially reasonable efforts to obtain the withdrawal or lifting of
such order at the earliest possible time, including, if necessary, by filing an
amendment to the Shelf Registration Statement or a new Shelf Registration Statement
and using commercially reasonable efforts to have such amendment or new Shelf
Registration Statement declared effective, and will provide to each Holder who is
named in the Shelf Registration Statement prompt notice of the withdrawal of any
such order or of the filing or effectiveness of any such amendment or new
registration statement.

(v) Make available at reasonable times for inspection by one or more
representatives of the selling Holders, designated in writing by a Majority of
Holders whose Transfer Restricted Securities are included in the Shelf Registration
Statement, and any attorney or accountant retained by such selling Holders and any
underwriter, if any, participating in any disposition pursuant to the Shelf
Registration Statement, all financial and other records, pertinent corporate
documents and properties of the Company as shall be reasonably necessary to enable
them to conduct a reasonable investigation within the meaning of Section 11 of the
Securities Act, and cause the Company’s officers, directors, managers and employees
to supply all information reasonably requested by any such representative or
representatives of the selling Holders, attorney or accountant in connection
therewith.

(vi) If requested by any selling Holders or the Initial Purchasers, promptly
incorporate in the Shelf Registration Statement or Prospectus, pursuant to a
supplement or post-effective amendment if necessary, such information as such
selling Holders may reasonably request to have included therein, including, without
limitation, information relating to the “Plan of Distribution” of the Transfer
Restricted Securities so as to enable such Holders to dispose of the Transfer
Restricted Securities in the manner contemplated herein.

(vii) Deliver to each selling Holder, without charge, as many copies of the
Prospectus (including each preliminary Prospectus) and any amendment or supplement
thereto, and any Issuer Free Writing Prospectus, as such Persons reasonably may
request; subject to Section 4(b)(ii) and subject to any notice by the Company in
accordance with this Section 4(b) of the existence of any fact or event of the kind
described in Section 4(b)(iv)(B) through (E), the Company hereby consents to the use
of the Prospectus and any amendment or supplement thereto, and any Issuer Free
Writing Prospectus, by each of the selling Holders in connection with the offering
and the sale of the Transfer Restricted Securities covered by the Prospectus or any
amendment or supplement thereto.

(viii) Before any public offering of Transfer Restricted Securities, cooperate
with the selling Holders and their counsel in connection with the registration and
qualification of the Transfer Restricted Securities under the securities or Blue Sky
laws of such jurisdictions in the United States as the selling Holders may
reasonably request and do any and all other acts or things necessary or advisable to
enable the disposition in such jurisdictions of the Transfer Restricted Securities
covered by the Shelf Registration Statement; provided, however, that the Company
shall not be required (A) to register or qualify as a foreign corporation or a
dealer of securities where it is not now so qualified or to take any action that
would subject it to the service of process in any jurisdiction where it is not now
so subject, other than service of process for suits arising out of the Initial
Placement or any offering pursuant to the Shelf Registration Statement, or (B) to
subject itself to general or unlimited service of process or to taxation in any such
jurisdiction if they are not now so subject.

(ix) Unless any Transfer Restricted Securities shall be in book-entry form
only, cooperate with the selling Holders to facilitate the timely preparation and
delivery of certificates representing Transfer Restricted Securities to be sold and
not bearing any restrictive legends (unless required by applicable securities laws);
and enable such Transfer Restricted Securities to be in such denominations and
registered in such names as the Holders may request at least two Business Days
before any sale of Transfer Restricted Securities.

(x) Use commercially reasonable efforts to cause the Transfer Restricted
Securities covered by the Shelf Registration Statement to be registered with or
approved by such other U.S. governmental agencies or authorities as may be necessary
to enable the seller or sellers thereof to consummate the disposition of such
Transfer Restricted Securities.

(xi) Subject to Section 4(b)(ii) hereof, if any fact or event contemplated by
Section 4(b)(iv)(B) through (D) hereof shall exist or have occurred, use
commercially reasonable efforts to prepare a supplement or post-effective amendment
to the Shelf Registration Statement, related Prospectus (including by means of an
Issuer Free Writing Prospectus), relevant Issuer Free Writing Prospectus or any
document incorporated therein by reference or to file any other required document so
that, as thereafter delivered to the purchasers of Transfer Restricted Securities,
none of the Registration Statement, the Prospectus or any Issuer Free Writing
Prospectus will contain an untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements
therein (in the case of the Prospectus and any such Issuer Free Writing Prospectus,
in the light of the circumstances in which they are made) not misleading.

(xii) Provide to DTC and the Trustee an unrestricted CUSIP number for the Notes
not later than the effective date of the Shelf Registration Statement and provide
the Trustee with certificates for the Notes that are in a form eligible for deposit
with DTC.

(xiii) Cooperate and assist in any filings required to be made with FINRA and
in the performance of any due diligence investigation by any underwriter that is
required to be undertaken in accordance with the rules and regulations of FINRA.

(xiv) Otherwise use commercially reasonable efforts to comply with all
applicable rules and regulations of the Commission and all reporting requirements
under the rules and regulations of the Exchange Act.

(xv) Make generally available to its security holders an earnings statement
satisfying the provisions of Section 11(a) of the Securities Act as soon as
practicable after the effective date of the Shelf Registration Statement and in any
event no later than 40 days after the end of the 12-month period (or 75 days, if
such period is a fiscal year) beginning with the first month of the Company’s first
fiscal quarter commencing after the effective date of the Shelf Registration
Statement.

(xvi) Cause the Indenture to be qualified under the TIA not later than the
effective date of the Shelf Registration Statement required by this Agreement (or
the time when the registration as to the Notes under the Shelf Registration
Statement is required to become effective hereunder), and, in connection therewith,
cooperate with the Trustee and the holders of Notes to effect such changes to the
Indenture as may be required for such Indenture to be so qualified in accordance
with the terms of the TIA; and execute and use commercially reasonable efforts to
cause the Trustee thereunder to execute all documents that may be required to effect
such changes and all other forms and documents required to be filed with the
Commission to enable such Indenture to be so qualified in a timely manner. In the
event that any such amendment or modification referred to in this Section 4(b)(xvi)
involves the appointment of a new trustee under the Indenture, the Company shall
appoint a new trustee thereunder pursuant to the applicable provisions of the
Indenture.

(xvii) Cause all Common Stock covered by the Shelf Registration Statement to be
listed or quoted, as the case may be, on each securities exchange on which Common
Stock is then listed.

(xviii) Provide to each Holder upon written request each document filed with
the Commission pursuant to the requirements of Section 13 and Section 15 of the
Exchange Act after the effective date of the Shelf Registration Statement, unless
such document is available through the Commission’s EDGAR system.

(xix) Use commercially reasonable efforts, if the Notes have been rated prior
to the initial sale of such Notes, to confirm such ratings will apply to the Notes
covered by the Shelf Registration Statement.

(xx) Subject to Section 8(d), in connection with any underwritten offering
conducted pursuant to Section 8 hereof, make such representations and warranties to
the Holders of Securities registered thereunder and the underwriters, in form,
substance and scope as are customarily made by issuers to underwriters in primary
underwritten offerings and covering matters including, but not limited to, those set
forth in the Purchase Agreement;

(xxi) Subject to Section 8(d), in connection with any underwritten offering
conducted pursuant to Section 8 hereof, obtain opinions of counsel to the Company
and updates thereof (which counsel and opinions (in form, scope and substance) shall
be reasonably satisfactory to the Managing Underwriters) addressed to each selling
Holder and the underwriters, if any, covering such matters as are customarily
covered in opinions requested in underwritten offerings and such other matters as
may be reasonably requested by such Holders and underwriters;

(xxii) Subject to Section 8(d), in connection with any underwritten offering
conducted pursuant to Section 8, hereof, obtain “comfort” letters and updates
thereof from the independent certified public accountants of the Company (and, if
necessary, any other independent certified public accountants of any subsidiary of
the Company or of any business acquired by the Company for which financial
statements and financial data are, or are required to be, included in the Shelf
Registration Statement), addressed to each selling Holder of Securities registered
thereunder and the underwriters, in customary form and covering matters of the type
customarily covered in “comfort” letters in connection with primary underwritten
offerings; and

(xxiii) Subject to Section 8(d), in connection with any underwritten offering
conducted pursuant to Section 8 hereof, deliver such documents and certificates as
may be reasonably requested by the Majority Holders and the Managing Underwriters,
including those to evidence compliance with Section 4(b)(iii) hereof and with any
customary conditions contained in the Purchase Agreement or other agreement entered
into by the Company.

(xxiv) Subject to Section 8(d), in connection with underwritten offering
conducted pursuant to Section 8 hereof, the Company shall, if requested, promptly
include or incorporate in a Prospectus supplement or post-effective amendment to the
Shelf Registration Statement such information as the Managing Underwriters
reasonably agree should be included therein and to which the Company does not
reasonably object and shall make all required filings of such Prospectus supplement
or post-effective amendment as soon as practicable after it is notified of the
matters to be included or incorporated in such Prospectus supplement or
post-effective amendment.

(xxv) Use commercially reasonable efforts to take all other steps necessary to
effect the registration of the Transfer Restricted Securities covered by the Shelf
Registration Statement.

(xxvi) Enter into customary agreements (including, if requested, an
underwriting agreement in customary form) and take all other reasonable actions in
order to expedite or facilitate the registration or the disposition of the Transfer
Restricted Securities, and in connection therewith and subject to Section 8(d), if
an underwriting agreement is entered into, cause the same to contain indemnification
provisions and procedures no less favorable than those set forth in Section 6
hereof.

The actions set forth in clauses (xxi), (xxii), (xxiii) and (xxiv) of this Section 4(b) shall
be performed at (A) the effectiveness of the Shelf Registration Statement and each post-effective
amendment thereto; and (b) each closing under any underwriting or similar agreement, if any, as and
to the extent required thereunder.

(c) Each Holder agrees by acquisition of a Transfer Restricted Security that, upon
receipt of any notice (a “Suspension Notice”) from the Company of the existence of any fact
of the kind described in Section 4(b)(iv)(B) through (E) hereof, such Holder will forthwith
discontinue disposition of Transfer Restricted Securities pursuant to the Shelf Registration
Statement and use of the Prospectus and any related Free Writing Prospectuses until:

(i) such Holder has received copies of the supplemented or amended Prospectus
or applicable Issuer Free Writing Prospectus contemplated by Section 4(b)(xi)
hereof; or

(ii) such Holder is advised in writing by the Company that the use of the
Prospectus and any applicable Issuer Free Writing Prospectus may be resumed, and has
received copies of any additional or supplemental filings that are incorporated by
reference in the Prospectus.

If so directed by the Company, each Holder will deliver to the Company (at the Company’s expense)
all copies, other than permanent file copies then in such Holder’s possession, of the Prospectus
covering such Transfer Restricted Securities and any Issuer Free Writing Prospectus that was
current at the time of receipt of such Suspension Notice.

(d) Each Holder agrees by acquisition of a Transfer Restricted Security, that no Holder
shall be entitled to sell any of such Transfer Restricted Securities pursuant to a
Registration Statement, or to receive a Prospectus relating thereto, unless such Holder has
furnished the Company with a Notice and Questionnaire as required pursuant to Section 2(b)
or Section 2(f) hereof (including the information required to be included in such Notice and
Questionnaire) and the information set forth in the next sentence. The Company may require
each Notice Holder of Notes to be sold pursuant to the Shelf Registration Statement to
furnish to the Company such information regarding the Holder and the distribution of such
Notes as the Company may from time to time reasonably require for inclusion in such
Registration Statement. Each Notice Holder agrees promptly to furnish to the Company all
information required to be disclosed in order to make the information previously furnished
to the Company by such Notice Holder not misleading and any other information regarding such
Notice Holder and the distribution of such Transfer Restricted Securities as the Company may
from time to time reasonably request in writing. The Company may exclude from such Shelf
Registration Statement the Notes of any Holder that unreasonably fails to furnish such
information within a reasonable time after receiving such request.

5. Registration Expenses.

All expenses incident to the Company’s performance of or compliance with this Agreement
shall be borne by the Company regardless of whether a Shelf Registration Statement becomes
effective, including, without limitation:

(a) all registration and filing fees and expenses (including filings made with FINRA);

(b) all fees and expenses of compliance with federal securities and state Blue Sky or
securities laws;

(c) all expenses of printing (including printing of Prospectuses, Issuer Free Writing
Prospectuses and certificates for the Common Stock to be issued upon conversion of the
Notes) and the Company’s expenses for messenger and delivery services and telephone;

(d) all fees and disbursements of counsel to the Company;

(e) all application and filing fees in connection with listing (or authorizing for
quotation) the Common Stock on a national securities exchange or automated quotation system
pursuant to the requirements hereof; and

(f) all fees and disbursements of independent certified public accountants of the
Company.

The Company shall bear its internal expenses (including, without limitation, all salaries and
expenses of their officers and employees performing legal, accounting or other duties), the
expenses of any annual audit and the fees and expenses of any Person, including special experts,
retained by the Company. Subject to Section 8(d), the Company shall pay all expenses customarily
borne by issuers in an underwritten offering as set forth in Section 8(c) hereof.

6. Indemnification And Contribution.

(a) The Company agrees to indemnify and hold harmless each Holder (including each
Initial Purchaser), its directors, officers, employees and agents, and each person, if any,
who controls any Holder within the meaning of the Securities Act or the Exchange Act (each,
an “Indemnified Holder”), against any loss, claim, damage, liability or expense, as
incurred, or any action in respect thereof (including, but not limited to, any loss, claim,
damage, liability or expense relating to resales of the Transfer Restricted Securities)
(collectively, “Losses”), to which such Indemnified Holder may become subject, insofar as
any such Loss arises out of or is based upon:

(i) any untrue statement or alleged untrue statement of a material fact
contained in the Shelf Registration Statement as originally filed or in any
amendment thereof or the omission or alleged omission to state therein any material
fact required to be stated therein or necessary to make the statements therein not
misleading; or

(ii) any untrue statement or alleged untrue statement of a material fact
contained in any Issuer Free Writing Prospectus, any preliminary prospectus or the
Prospectus (or any amendment or supplement thereto), or the omission or alleged
omission therefrom of a material fact, in each case, necessary in order to make the
statements therein, in the light of the circumstances under which they were made,
not misleading,

and to reimburse each Indemnified Holder for any and all expenses including the fees and
disbursements of counsel as such expenses are reasonably incurred by such Indemnified Holder
in connection with investigating, defending, settling, compromising or paying any such Loss;
provided, however, that the foregoing indemnity agreement shall not apply to any Loss to the
extent, but only to the extent, arising out of or based upon any untrue statement or alleged
untrue statement or omission or alleged omission made in reliance upon and in conformity
with written information furnished to the Company by or on behalf of such Holder (or its
related Indemnified Holder) expressly for use therein. The indemnity agreement set forth in
this Section 6(a) shall be in addition to any liabilities that the Company may otherwise
have.

The Company, subject to Section 8(d), also agrees to indemnify as provided in this
Section 6(a) or contribute as provided in Section 6(e) hereof to Losses of each underwriter,
if any, of Transfer Restricted Securities registered under a Shelf Registration Statement,
their directors, officers, employees or agents and each person who controls such underwriter
on substantially the same basis as that of the indemnification of the Initial Purchasers and
the selling Holders provided in this Section 6(a) and shall, if requested by any Holder,
enter into an underwriting agreement reflecting such agreement, as provided in Section
4(b)(xxvi) hereof.

(b) Each Holder agrees, severally and not jointly, to indemnify and hold harmless the
Company, each of its directors, each of its officers who sign the Shelf Registration
Statement and each person, if any, who controls the Company within the meaning of the
Securities Act or the Exchange Act (i) to the same extent as the foregoing indemnity from
the Company to each such Holder, but only with reference to written information relating to
such Holder furnished to the Company by or on behalf of such Holder (or otherwise furnished
by the underwriters) specifically for inclusion in the documents referred to in the
foregoing indemnity and (ii) against any Loss, joint or several, including, but not limited
to, any Loss relating to resales of the Transfer Restricted Securities, to which such person
may become subject, insofar as any such Loss arises out of, or is based upon any Free
Writing Prospectus used by such Holder without the prior consent of the Issuer, and in
connection with any underwritten offering, the underwriters, provided that the
indemnification obligation in this clause (ii) shall be several, not joint and several,
among the Holders who used such Free Writing Prospectus. This indemnity agreement set forth
in this Section shall be in addition to any liabilities which any such Holder may otherwise
have.

(c) Promptly after receipt by an indemnified party under this Section 6 of notice of
the commencement of any action, such indemnified party will, if a claim in respect thereof
is to be made against an indemnifying party under this Section 6, notify the indemnifying
party in writing of the commencement thereof, but the failure to notify the indemnifying
party (i) will not relieve it from liability under paragraph (a) or (b) above unless and to
the extent it did not otherwise learn of such action and such failure results in the
forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not,
in any event, relieve the indemnifying party from any obligations to any indemnified party
other than the indemnification obligation provided in paragraph (a) or (b) above. In case
any such action is brought against any indemnified party and such indemnified party seeks or
intends to seek indemnity from an indemnifying party, the indemnifying party will be
entitled to participate in, and, to the extent that it shall elect, jointly with all other
indemnifying parties similarly notified, by written notice delivered to the indemnified
party promptly after receiving the aforesaid notice from such indemnified party, to assume
the defense thereof with counsel satisfactory to such indemnified party; provided, however,
if the defendants in any such action include both the indemnified party and the indemnifying
party and the indemnified party shall have reasonably concluded that a conflict may arise
between the positions of the indemnifying party and the indemnified party in conducting the
defense of any such action or that there may be legal defenses available to it and/or other
indemnified parties that are different from or additional to those available to the
indemnifying party, the indemnified party or parties shall have the right to select separate
counsel to assume such legal defenses and to otherwise participate in the defense of such
action on behalf of such indemnified party or parties. Upon receipt of notice from the
indemnifying party to such indemnified party of such indemnifying party’s election so to
assume the defense of such action and approval by the indemnified party of counsel, the
indemnifying party will not be liable to such indemnified party under this Section 6 for any
legal or other expenses subsequently incurred by such indemnified party in connection with
the defense thereof unless (i) the indemnified party shall have employed separate counsel in
accordance with the proviso to the preceding sentence (it being understood, however, that
the indemnifying party shall not be liable for the expenses of more than one separate
counsel (other than local counsel), reasonably approved by the indemnifying party,
representing the indemnified parties who are parties to such action) or (ii) the
indemnifying party shall not have employed counsel satisfactory to the indemnified party to
represent the indemnified party within a reasonable time after notice of commencement of the
action, in each of which cases the fees and expenses of counsel shall be at the expense of
the indemnifying party.

(d) The indemnifying party under this Section 6 shall not be liable for any settlement
of any proceeding effected without its written consent, which shall not be withheld
unreasonably, but if settled with such consent or if there is a final judgment for the
plaintiff, the indemnifying party agrees to indemnify the indemnified party against any Loss
by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any
time an indemnified party shall have requested an indemnifying party to reimburse the
indemnified party for fees and expenses of counsel as contemplated by Section 6(c) hereof,
the indemnifying party agrees that it shall be liable for any settlement of any proceeding
effected without its written consent if (i) such settlement is entered into more than 30
days after receipt by such indemnifying party of the aforesaid request and (ii) such
indemnifying party shall not have reimbursed the indemnified party in accordance with such
request prior to the date of such settlement. No indemnifying party shall, without the
prior written consent of the indemnified party, effect any settlement, compromise or consent
to the entry of judgment in any pending or threatened action, suit or proceeding in respect
of which any indemnified party is or could have been a party and indemnity was or could have
been sought hereunder by such indemnified party, unless such settlement, compromise or
consent (x) includes an unconditional release of such indemnified party from all liability
on claims that are the subject matter of such action, suit or proceeding and (y) does not
include a statement as to or an admission of fault, culpability or a failure to act, by or
on behalf of any indemnified party.

(e) If the indemnification provided for in Section 6 is for any reason unavailable to
or otherwise insufficient to hold harmless an indemnified party in respect of any Loss
referred to therein, then each indemnifying party shall contribute to the aggregate amount
paid or payable by such indemnified party, as incurred, as a result of any Loss referred to
therein:

(i) in such proportion as is appropriate to reflect the relative benefits
received by the Company, on the one hand, and the Holders, on the other hand, from
the offering and sale of the Transfer Restricted Securities, on the one hand, and a
Holder with respect to the sale by such Holder of the Transfer Restricted
Securities, on the other hand, or

(ii) if the allocation provided by Section (6)(e)(i) above is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in Section 6(e)(i) above but also the relative fault
of the Company, on the one hand, and the Holders, on the other hand, in connection
with the statements or omissions or alleged statements or omissions that resulted in
such Loss, as well as any other relevant equitable considerations.

The relative benefits received by the Company, on the one hand, and the Holders, on the
other hand, in connection with such offering and such sale of the Transfer Restricted
Securities pursuant to this Agreement shall be deemed to be in the same respective
proportions as the total net proceeds from the offering of the Notes purchased under the
Purchase Agreement (before deducting expenses) received by the Company and the total
proceeds received by the Holders with respect to their sale of Transfer Restricted
Securities. The relative fault of the Company, on the one hand, and the Holders, on the
other hand, shall be determined by reference to, among other things, whether any such untrue
or alleged untrue statement of a material fact or omission or alleged omission to state a
material fact relates to information supplied by the Company, on the one hand, or the
Holders, on the other hand, and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission. The Company
and the Holders agree that it would not be just and equitable if contribution pursuant to
this Section 6(e) were determined by pro rata allocation (even if the Holders were treated
as one entity for such purpose) or by any other method of allocation that does not take
account of the equitable considerations referred to in this Section 6(e).

The amount paid or payable by a party as a result of the Loss referred to above shall
be deemed to include, subject to the limitations set forth in Section 6(c), any legal or
other fees or expenses reasonably incurred by such party in connection with investigating or
defending any action or claim.

Notwithstanding the provisions of this Section 6, in no event will (i) any Holder be
required to undertake liability to any person under this Section 6 for any amounts in excess
of the dollar amount of the proceeds to be received by such Holder from the sale of such
Holder’s Transfer Restricted Securities (after deducting any fees, discounts and commissions
applicable thereto) pursuant to any Shelf Registration Statement under which such Transfer
Restricted Securities are to be registered under the Securities Act and (ii) any underwriter
be required to undertake liability to any person hereunder for any amounts in excess of the
discount or commission payable to such underwriter with respect to the Transfer Restricted
Securities underwritten by it and distributed to the public. No Person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation. The Holders’ obligations to contribute as provided in this Section 6(e)
are several and not joint.

(f) The provisions of this Section 6 shall remain in full force and effect, regardless
of any investigation made by or on behalf of any Holder or the Company or any of the
officers, directors, employees, agents or controlling persons referred to in Section 6
hereof, and will survive the sale by a Holder of Transfer Restricted Securities.

7. Rule 144A and Rule 144. The Company agrees with each Holder, for so long as any Transfer
Restricted Securities remain outstanding and during any period in which the Company (i) is not
subject to Section 13 or 15(d) of the Exchange Act, to make available to such Holder of Transfer
Restricted Securities in connection with any sale thereof and any prospective purchaser of such
Transfer Restricted Securities designated by such Holder, any information as such Holder may
reasonably request in writing (including, without limitation, information required by paragraph
(d)(4) of Rule 144A and making such representations as any such Holder may reasonably request) in
order to permit resales of such Transfer Restricted Securities without registration under the
Securities Act pursuant to Rule 144A and (ii) is subject to Section 13 or 15(d) of the Exchange
Act, to make all filings required thereby in order to permit resales of such Transfer Restricted
Securities pursuant to Rule 144.

8. Underwritten Registrations.

(a) Subject to Section 8(d), any Holder of Transfer Restricted Securities who desires
to do so may sell Transfer Restricted Securities (in whole or in part) in an underwritten
offering; provided that (i) the Electing Holders of at least 33-1/3% in aggregate principal
amount of the Transfer Restricted Securities then covered by the Shelf Registration
Statement shall request such an offering and (ii) at least such aggregate principal amount
of such Transfer Restricted Securities shall be included in such offering; and provided,
further, that the Company shall not be obligated to participate in more than one
underwritten offering during the Effectiveness Period. Upon receipt of such a request, the
Company shall provide all Holders of Transfer Restricted Securities written notice of the
request, which notice shall inform such Holders that they have the opportunity to
participate in the offering. If any of the Transfer Restricted Securities covered by the
Shelf Registration Statement are to be sold in an underwritten offering, the Managing
Underwriters shall be selected by the Majority Holders.

(b) No person may participate in any underwritten offering pursuant to the Shelf
Registration Statement unless such person (i) agrees to sell such person’s Transfer
Restricted Securities on the basis reasonably provided in any underwriting arrangements
approved by the persons entitled hereunder to approve such arrangements; (ii) completes and
executes all questionnaires, powers of attorney, indemnities, underwriting agreements and
other documents reasonably required under the terms of such underwriting arrangements; and
(iii) if such Holder is not then a Notice Holder, such Holder returns a completed and signed
Notice and Questionnaire to the Company in accordance with Section 2(b) or Section 2(f)
hereof within a reasonable amount of time before such underwritten offering.

(c) The Holders participating in any underwritten offering shall be responsible for any
underwriting discounts and commissions and fees and, subject to Section 5 hereof, expenses
of their own counsel. The Company shall pay all expenses customarily borne by issuers in an
underwritten offering, including but not limited to filing fees, the fees and disbursements
of its counsel and independent public accountants and any printing expenses incurred in
connection with such underwritten offering. Notwithstanding the foregoing or the provisions
of Section 4(b)(xxiv) hereof, upon receipt of a request from the Managing Underwriter or a
representative of holders of a majority of the Transfer Restricted Securities to be included
in an underwritten offering to prepare and file an amendment or supplement to the Shelf
Registration Statement and Prospectus in connection with an underwritten offering, the
Company may delay the filing of any such amendment or supplement for up to 90 days if the
Board of Directors of the Company shall have determined in good faith that the Company has a
bona fide business reason for such delay.

(d) Notwithstanding any provision of this Agreement to the contrary, in no event will
the distribution of Transfer Restricted Securities take the form of an underwritten offering
without the express written consent of the Company, such consent to be solely at the
discretion of the Company.

9. Miscellaneous.

(a) Free Writing Prospectuses. Each Holder represents that it has not prepared or had
prepared on its behalf or used or referred to, and agrees that it will not prepare or have
prepared on its behalf or use or refer to, any Free Writing Prospectus, and has not
distributed and will not distribute any written materials in connection with the offer or
sale of the Transfer Restricted Securities without the prior express written consent of the
Company and, in connection with any underwritten offering, the underwriters. Any such Free
Writing Prospectus consented to by the Company and, if applicable, the underwriters, as the
case may be, is hereinafter referred to as a “Permitted Free Writing Prospectus.” The
Company represents and agrees that it has treated and will treat, as the case may be, each
Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus, including in respect
of timely filing with the Commission, legending and recordkeeping.

(b) Remedies. The Company acknowledges and agrees that any failure by the Company to
comply with its obligations under Section 2 hereof may result in material irreparable injury
to the Initial Purchasers or the Holders for which there is no adequate remedy at law, that
it will not be possible to measure damages for such injuries precisely, and that, in the
event of any such failure, in addition to being entitled to exercise all rights provided to
it herein, in the Indenture or in the Purchase Agreement or granted by law, including
recovery of damages (other than the recovery of damages for a breach by the Company of its
obligations under Section 2 hereof for which Additional Interest has been paid pursuant to
Section 2 hereof), the Initial Purchasers or any Holder may obtain such relief as may be
required to specifically enforce the Company’s obligations under Section 2 hereof. The
Company further agrees to waive the defense in any action for specific performance that a
remedy at law would be adequate.

(c) Actions Affecting Transfer Restricted Securities. The Company shall not, directly
or indirectly, take any action with respect to the Transfer Restricted Securities as a class
that would adversely affect the ability of the Holders of Transfer Restricted Securities to
include such Transfer Restricted Securities in a registration undertaken pursuant to this
Agreement.

(d) No Inconsistent Agreements. The Company has not, as of the date hereof, entered
into, nor shall it, on or after the date hereof, enter into, any agreement with respect to
its securities that is inconsistent with the rights granted to the Holders in this Agreement
or otherwise conflicts with the provisions hereof. In addition, the Company shall not grant
to any of its securityholders (other than the Holders of Transfer Restricted Securities in
such capacity) the right to include any of its securities in the Shelf Registration
Statement provided for in this Agreement other than the Transfer Restricted Securities.

(e) Amendments and Waivers. This Agreement may not be amended, modified or
supplemented, and waivers or consents to or departures from the provisions hereof may not be
given, unless the Company has obtained the written consent of a Majority of Holders;
provided, however, that with respect to any matter that directly or indirectly adversely
affects the rights of any Initial Purchaser hereunder, the Company shall obtain the written
consent of each such Initial Purchaser against which such amendment, qualification,
supplement, waiver or consent is to be effective. Notwithstanding the foregoing (except the
foregoing proviso), a waiver or consent to depart from the provisions hereof with respect to
a matter that relates exclusively to the rights of Holders whose securities are being sold
pursuant to a Shelf Registration Statement and does not directly or indirectly adversely
affect the rights of other Holders, may be given by the Majority Holders, determined on the
basis of Transfer Restricted Securities being sold rather than registered under such Shelf
Registration Statement.

(f) Notices. All notices and other communications provided for or permitted hereunder
shall be made in writing by hand delivery, first class mail (registered or certified, return
receipt requested), facsimile transmission, or air courier guaranteeing overnight delivery:

(i) if to a Holder, at the address set forth on the records of the registrar
under the Indenture or the transfer agent of the Common Stock, as the case may be;
and

(ii) if to the Company, initially at its address set forth in the Purchase
Agreement.

All such notices and communications shall be deemed to have been duly given: at the
time delivered by hand, if personally delivered; five Business Days after being deposited in
the mail, postage prepaid, if mailed; when receipt acknowledged, if transmitted by
facsimile; and on the next Business Day, if timely delivered to an air courier guaranteeing
overnight delivery.

Any party hereto may change the address for receipt of communications by giving written notice
to the others.

(g) Successors and Assigns. This Agreement shall inure to the benefit of and be
binding upon the successors and assigns of each of the parties, including without limitation
and without the need for an express assignment, subsequent Holders of Transfer Restricted
Securities. The Company hereby agrees to extend the benefit of this Agreement to any Holder
and any such Holder may specifically enforce the provisions of this Agreement as if an
original party hereto.

(h) Counterparts. This Agreement may be executed in any number of counterparts and by
the parties hereto in separate counterparts, each of which when so executed shall be deemed
to be an original and all of which taken together shall constitute one and the same
agreement.

(i) Notes Held by the Company or Their Affiliates. Whenever the consent or approval of
Holders of a specified percentage of Transfer Restricted Securities is required hereunder,
Transfer Restricted Securities held by the Company or its Affiliates (other than subsequent
Holders if such subsequent Holders are deemed to be Affiliates solely by reason of their
holding of such Transfer Restricted Securities) shall not be counted in determining whether
such consent or approval was given by the Holders of such required percentage.

(j) Headings. The headings in this Agreement are for convenience of reference only and
shall not limit or otherwise affect the meaning hereof.

(k) GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAW OF THE STATE OF NEW YORK.

(l) Severability. If any one or more of the provisions contained herein, or the
application thereof in any circumstance, is held invalid, illegal or unenforceable, the
validity, legality and enforceability of any such provision in every other respect and of
the remaining provisions contained herein shall not be affected or impaired thereby, it
being intended that all of the rights and privileges of the parties shall be enforceable to
the fullest extent permitted by law.

(m) Entire Agreement. This Agreement is intended by the parties as a final expression
of their agreement and intended to be a complete and exclusive statement of the agreement
and understanding of the parties hereto in respect of the subject matter contained herein.
There are no restrictions, promises, warranties or undertakings, other than those set forth
or referred to herein with respect to the registration rights granted by the Company with
respect to the Transfer Restricted Securities. This Agreement supersedes all prior
agreements and understandings between the parties with respect to such subject matter.

2

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first
written above.

ALASKA COMMUNICATIONS SYSTEMS

GROUP, INC.

By: /s/ David Wilson

Name: David Wilson

Title: Senior Vice President and Chief

Financial Officer

	 	 	 
	ALASKA COMMUNICATIONS SYSTEMS	 	 
	HOLDINGS, INC.	 	ACS OF THE NORTHLAND, INC.
	By: /s/ David Wilson

	 	By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer
	ACS OF ALASKA, INC.

By: /s/ David Wilson

	 	ACS OF FAIRBANKS, INC.

By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer
	ACS OF ANCHORAGE, INC.

By: /s/ David Wilson

	 	ACS WIRELESS, INC.

By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	 	 

	 	 	 
	ACS LONG DISTANCE, INC.	 	ACS INTERNET, INC.
	By: /s/ David Wilson

	 	By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer
	ACS INFOSOURCE, INC.

By: /s/ David Wilson

	 	ACS CABLE SYSTEMS, INC.

By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer
	ACS SERVICE, INC.

By: /s/ David Wilson

	 	ACS MESSAGING, INC.

By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

3

	 	 	BANC OF AMERICA SECURITIES LLC

By: /s/ Richard Swift

Name: Richard Swift

Title: Global Head of Media & Telecom

Investment Banking

OPPENHEIMER & CO. INC.

By: /s/ Andrew MacInnes

Name: Andrew MacInnes

Title: Managing Director

4EX-10.1

$110,000,000 AGGREGATE PRINCIPAL AMOUNT

ALASKA COMMUNICATIONS SYSTEMS GROUP, INC.

5.75% CONVERTIBLE NOTES

DUE 2013

1

Purchase Agreement

dated April 2, 2008Purchase Agreement

April 2, 2008

BANC OF AMERICA SECURITIES LLC

OPPENHEIMER & CO. INC.

As the Representatives of the several Initial Purchasers

9 West 57th Street

New York, New York 10019

Ladies and Gentlemen:

Alaska Communications Systems Group, Inc., a Delaware corporation (the “Company”), proposes to
issue and sell to the several purchasers named in Schedule A (the “Initial Purchasers”)
$110,000,000 in aggregate principal amount of its 5.75% Convertible Notes due 2013 (the “Firm
Notes”), guaranteed on a joint and several basis by the subsidiaries of the Company listed in
Schedule D and each domestic subsidiary of the Company hereafter created or acquired, other than
its license subsidiaries, (the “Guarantors,” and such guarantees, the “Firm Guarantees”). In
addition, the Company has granted to the Initial Purchasers an option to purchase up to an
additional $15,000,000 in aggregate principal amount of its 5.75% Convertible Notes due 2013 (the
“Optional Notes” and, together with the Firm Notes, the “Notes”), as provided in Section 2,
guaranteed by the Guarantors (such guarantees, the “Optional Guarantees” and, together with the
Firm Guarantees, the “Guarantees”). Banc of America Securities LLC (“BAS”) and Oppenheimer & Co.
Inc. (“Oppenheimer”) have agreed to act as the representatives of the several Initial Purchasers
(in such capacity, the “Representatives”) in connection with the offering and sale of the Notes.
To the extent that there are no additional Initial Purchasers listed on Schedule A other
than you, the terms “Representatives” and “Initial Purchasers” as used herein shall mean you, as
Initial Purchasers. The terms “Representatives” and “Initial Purchasers” shall mean either the
singular or plural as the context requires.

The Notes will be convertible on the terms, and subject to the conditions, set forth in the
indenture (the “Indenture”) to be entered into among the Company, the Guarantors and the The Bank
of New York Trust Company, N.A., as trustee (the “Trustee”), on the Closing Date (as defined
herein). As used herein, “Conversion Shares” means the fully paid, nonassessable shares of common
stock, par value $0.01 per share, of the Company (the “Common Stock”) to be received by the holders
of the Notes upon conversion of the Notes pursuant to the terms of the Notes and the Indenture.
The Notes will be convertible initially at a conversion rate of 77.5013 shares per $1,000 principal
amount of the Notes, on the terms, and subject to the conditions, set forth in the Indenture. In
connection with the offering of the Notes, the Company is entering into convertible note hedge and
warrant transactions with Bank of America, N.A. and certain other counterparties pursuant to
confirmation letters, dated April 2, 2008, to the form of the ISDA 2002 Master Agreement (the
“Convertible Note Hedge and Warrant Transaction Documentation”).

The Notes will be offered and sold to the Initial Purchasers without being registered under
the Securities Act of 1933, as amended, and the rules and regulations of the Securities and
Exchange Commission (the “Commission”) thereunder (the “Securities Act”), in reliance upon an
exemption therefrom.

Holders of the Notes (including the Initial Purchasers and their direct and indirect
transferees) will be entitled to the benefits of a Resale Registration Rights Agreement, dated the
Closing Date, between the Company and the Initial Purchasers (the “Registration Rights Agreement”),
pursuant to which, with respect to any Notes held by non-affiliates of the Company that are not
freely transferable under Rule 144 under the Securities Act, the Company will agree to file or have
on file with the Commission a shelf registration statement pursuant to Rule 415 under the
Securities Act (the “Registration Statement”) covering the resale of the Notes and the related
Conversion Shares, subject to certain conditions. This Agreement, the Indenture, the Notes, the
Guarantees and the Registration Rights Agreement are referred to herein collectively as the
“Operative Documents.”

The Company understands that the Initial Purchasers propose to make an offering of the Notes
on the terms and in the manner set forth herein and in the Disclosure Package (as defined below),
including the Preliminary Offering Memorandum (as defined below), and the Final Offering Memorandum
(as defined below) and agrees that the Initial Purchasers may resell, subject to the conditions set
forth herein, all or a portion of the Notes to purchasers at any time after the date of this
Agreement.

The Company has prepared an offering memorandum, dated the date hereof, setting forth
information concerning the Company, the Notes, the Registration Rights Agreement and the Common
Stock, in form and substance reasonably satisfactory to the Initial Purchasers. As used in this
Agreement, “Offering Memorandum” means, collectively, the Preliminary Offering Memorandum dated as
of April 2, 2008 (the “Preliminary Offering Memorandum”) and the offering memorandum dated the date
hereof (the “Final Offering Memorandum”), each as then amended or supplemented by the Company. As
used herein, each of the terms “Disclosure Package,” “Offering Memorandum,” “Preliminary Offering
Memorandum” and “Final Offering Memorandum” shall include in each case the documents incorporated
or deemed to be incorporated by reference therein.

The Company hereby confirms its agreements with the Initial Purchasers as follows:

Section 1. Representations, Warranties and Covenants of the Company and the Guarantors.

Each of the Company and the Guarantors, jointly and severally, hereby represent and warrant
to, and covenant with, each Initial Purchaser as follows:

(a) No Registration. Assuming the accuracy of the representations and warranties of the
Initial Purchasers contained in Section 6 and their compliance with the agreements set forth
therein, it is not necessary, in connection with the issuance and sale of the Notes to the Initial
Purchasers, the initial offer, resale and delivery of the Notes by the Initial Purchasers and the
conversion of the Notes into Conversion Shares, in each case in the manner contemplated by this
Agreement, the Indenture, the Disclosure Package and the Offering Memorandum, to register the Notes
or the Conversion Shares under the Securities Act or to qualify the Indenture under the Trust
Indenture Act of 1939, as amended (the “Trust Indenture Act”).

(b) No Integration. None of the Company or any of its subsidiaries has, directly or through
any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of,
any “security” (as defined in the Securities Act) that is or will be integrated with the sale of
the Notes or the Conversion Shares in a manner that would require registration of the Notes or the
Conversion Shares under the Securities Act.

(c) Rule 144A. No securities of the same class (within the meaning of Rule 144A(d)(3) under
the Securities Act) as the Notes are listed on any national securities exchange registered under
Section 6 of the Exchange Act, or quoted on an automated inter-dealer quotation system.

(d) Exclusive Agreement. Neither the Company nor any of the Guarantors has paid or agreed to
pay to any person any compensation for soliciting another person to purchase any securities of the
Company or the Guarantors (except as contemplated in this Agreement).

(e) Offering Memoranda. Each of the Company and the Guarantors hereby confirms that it has
authorized the use of the Disclosure Package and the Final Offering Memorandum in connection with
the offer and sale of the Notes by the Initial Purchasers. Each document, if any, filed or to be
filed pursuant to the Exchange Act and incorporated by reference in the Disclosure Package or the
Final Offering Memorandum complied when it was filed, or will comply when it is filed, as the case
may be, in all material respects with the Exchange Act and the rules and regulations of the
Commission thereunder. The Preliminary Offering Memorandum, at the date thereof, did not contain
any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading. At the date of this Agreement, the Closing Date and on any Subsequent Closing Date,
the Final Offering Memorandum did not and will not (and any amendment or supplement thereto, at the
date thereof, at the Closing Date and on any Subsequent Closing Date, will not) contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading;
provided that the Company makes no representation or warranty as to information contained
in or omitted from the Preliminary Offering Memorandum or the Final Offering Memorandum in reliance
upon and in conformity with written information furnished to the Company and the Guarantors by any
Initial Purchaser through BAS expressly for use therein, it being understood and agreed that the
only such information furnished by any Initial Purchaser consists of the information described as
such in Section 8 hereof.

(f) Disclosure Package. The term “Disclosure Package” shall mean (i) the Preliminary Offering
Memorandum, as amended or supplemented at the Applicable Time, (ii) the Final Term Sheet (as
defined herein) and (iii) any other writings that the parties expressly agree in writing to treat
as part of the Disclosure Package (“Issuer Written Information”). As of 5:30 p.m., New York time,
on the date of execution and delivery of this Agreement (the “Applicable Time”), the Disclosure
Package did not contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading. The preceding sentence does not apply to statements in or
omissions from the Disclosure Package based upon and in conformity with written information
furnished to the Company and the Guarantors by any Initial Purchaser through BAS expressly for use
therein, it being understood and agreed that the only such information furnished by any Initial
Purchaser consists of the information described as such in Section 8 hereof.

(g) Statements in Offering Memorandum. The statements in the Disclosure Package and the Final
Offering Memorandum under the heading “Certain United States Federal Income Tax Consequences,”
insofar as such statements summarize legal matters are accurate and fair summaries of such legal
matters.

(h) Offering Materials Furnished to Initial Purchasers. To the extent not publicly available,
the Company has delivered to the Representatives copies of the materials contained in the
Disclosure Package and the Final Offering Memorandum, each as amended or supplemented, in such
quantities and at such places as the Representatives have reasonably requested for each of the
Initial Purchasers.

(i) Authorization of the Purchase Agreement. This Agreement has been duly authorized,
executed and delivered by the Company and each of the Guarantors.

(j) Authorization of the Indenture. The Indenture has been duly authorized by the Company and
each of the Guarantors and, in the event a Registration Statement is required to be prepared and
filed in accordance with the Registration Rights Agreement, upon effectiveness of such Registration
Statement, will be qualified under the Trust Indenture Act; on the Closing Date, the Indenture will
have been duly executed and delivered by the Company and each of the Guarantors, respectively, and,
assuming due authorization, execution and delivery thereof by the Trustee, will constitute a valid
and legally binding agreement of the Company and each of the Guarantors enforceable against the
Company and each of the Guarantors in accordance with its terms, except as enforcement thereof may
be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to
or affecting the rights and remedies of creditors or by general equitable principles; and the
Indenture conforms in all material respects to the description thereof contained in the Disclosure
Package and the Final Offering Memorandum.

(k) Authorization of the Notes. The Notes have been duly authorized by the Company; when the
Notes are executed, authenticated and issued in accordance with the terms of the Indenture and
delivered to and paid for by the Initial Purchasers pursuant to this Agreement on the Closing Date
or any Subsequent Closing Date, as the case may be, (assuming due authentication of the Notes by
the Trustee), such Notes will constitute valid and legally binding obligations of the Company,
entitled to the benefits of the Indenture and enforceable against the Company in accordance with
their terms, except as enforcement thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws relating to or affecting the rights and remedies
of creditors or by general equitable principles; and the Notes will conform in all material
respects to the description thereof contained in the Disclosure Package and the Final Offering
Memorandum.

(l) Authorization of the Guarantees. The Guarantees have been duly authorized by the
Guarantors; when the Guarantees are executed, authenticated and issued in accordance with the terms
of the Indenture and delivered to and paid for by the Initial Purchasers pursuant to this Agreement
on the respective Closing Date (assuming due authentication of the Guarantees by the Trustee), such
Guarantees will constitute valid and legally binding obligations of the Guarantors, entitled to the
benefits of the Indenture and enforceable against the Guarantors in accordance with their terms,
except as enforcement thereof may be limited by bankruptcy, insolvency, reorganization, or other
similar laws relating to or affecting the rights and remedies of creditors or by general equitable
principles; and the Guarantees will conform in all material respects to the description thereof
contained in the Disclosure Package and the Final Offering Memorandum.

(m) Authorization of the Conversion Shares. The Conversion Shares have been duly authorized
and reserved and, when issued upon conversion of the Notes in accordance with the terms of the
Notes and the Indenture, will be validly issued, fully paid and nonassessable, and the issuance of
such shares will not be subject to any preemptive or similar rights.

(n) Authorization of the Registration Rights Agreement. The Registration Rights Agreement has
been duly authorized, executed and delivered by the Company.

(o) Authorization of the Convertible Note Hedge and Warrant Transaction Documentation. The
Convertible Note Hedge and Warrant Transaction Documentation has been duly authorized, executed and
delivered by the Company, and, assuming due authorization, execution and delivery by the
counterparties thereto, will constitute a valid and legally binding agreement of the Company and
each of the Guarantors enforceable against the Company and each of the Guarantors in accordance
with its terms, except as enforcement thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws relating to or affecting the rights and remedies
of creditors or by general equitable principles; and the Convertible Note Hedge and Warrant
Transaction Documentation conforms in all material respects to the description contained in the
Disclosure Package and the Final Offering Memorandum.

(p) No Material Adverse Change. Except as otherwise disclosed in the Disclosure Package and
the Final Offering Memorandum (exclusive of any amendments or supplements thereto subsequent to the
date of this Agreement), subsequent to the respective dates as of which information is given in the
Disclosure Package: (i) there has been no material adverse change, or any development that could
reasonably be expected to result in a material adverse change, in the condition, financial or
otherwise, or in the earnings, business, properties, operations or prospects, whether or not
arising from transactions in the ordinary course of business, of the Company and its subsidiaries,
considered as one entity (any such change is called a “Material Adverse Change”); (ii) the Company
and its subsidiaries, considered as one entity, have not incurred any material liability or
obligation, indirect, direct or contingent, nor entered into any material transaction or agreement;
and (iii) there has been no dividend or distribution of any kind declared, paid or made by the
Company or, except for (x) dividends paid to the Company or other subsidiaries, any of its
subsidiaries on any class of capital stock or repurchase or redemption by the Company or any of its
subsidiaries of any class of capital stock and (y) the regular quarterly dividend of $0.215 per
share declared on the Company’s common stock to be paid on April 16, 2008.

(q) Independent Accountants. KPMG LLP, who have expressed their opinion with respect to the
financial statements (which term as used in this Agreement includes the related notes thereto) and
supporting schedules included as a part of or incorporated by reference in the Disclosure Package
and the Final Offering Memorandum, are independent registered public accountants with respect to
the Company as required by the Securities Act and the Exchange Act and the applicable published
rules and regulations thereunder.

(r) Preparation of the Financial Statements. The financial statements and the supporting
schedules included or incorporated by reference in the Disclosure Package and the Final Offering
Memorandum present fairly the consolidated financial position of the Company and its consolidated
subsidiaries as of and at the dates indicated and the results of their operations and cash flows
for the periods specified. Such financial statements and supporting schedules comply as to form
with the applicable accounting requirements of Regulation S-X and have been prepared in conformity
with generally accepted accounting principles as applied in the United States (“GAAP”) applied on a
consistent basis throughout the periods involved, except as may be expressly stated in the related
notes thereto. The financial data set forth in the Disclosure Package and the Final Offering
Memorandum under the captions “Summary—Summary Selected Financial Data”, “Selected Financial Data”
and “Capitalization” fairly present the information set forth therein on a basis consistent with
that of the audited financial statements contained in the Disclosure Package and the Final Offering
Memorandum. The Company’s ratios of earnings to fixed charges set forth in the Disclosure Package
and the Final Offering Memorandum have been calculated in compliance with Item 503(d) of Regulation
S-K under the Securities Act.

(s) Incorporation and Good Standing of the Company and its Subsidiaries. Each of the Company
and its subsidiaries has been duly incorporated and is validly existing as a corporation in good
standing under the laws of the jurisdiction of its incorporation and has corporate power and
authority to own or lease, as the case may be, and operate its properties and to conduct its
business as described in the Disclosure Package and the Final Offering Memorandum and, in the case
of the Company, to enter into and perform its obligations under this Agreement. The Company and
each of its subsidiaries is duly qualified as a foreign corporation to transact business and is in
good standing in each jurisdiction in which such qualification is required, whether by reason of
the ownership or leasing of property or the conduct of business, except for such jurisdictions
where the failure to so qualify or to be in good standing would not, individually or in the
aggregate, result in a material adverse effect on the condition, financial or otherwise, or on the
earnings, business, properties, operations or prospects, whether or not arising from transactions
in the ordinary course of business, of the Company and its subsidiaries, considered as one entity
(a “Material Adverse Effect”). All of the issued and outstanding shares of capital stock of each
subsidiary have been duly authorized and validly issued, are fully paid and nonassessable and are
owned by the Company, directly or through subsidiaries, free and clear of any security interest,
mortgage, pledge, lien, encumbrance or claim. The Company does not own or control, directly or
indirectly, any corporation, association or other entity other than the subsidiaries listed in
Exhibit 21 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007.

(t) Capitalization and Other Capital Stock Matters. The authorized, issued and outstanding
capital stock of the Company is as set forth in the Disclosure Package and the Final Offering
Memorandum under the caption “Capitalization” (other than for subsequent issuances, if any,
pursuant to employee benefit plans described in the Disclosure Package and the Final Offering
Memorandum or upon exercise of outstanding options or warrants described in the Disclosure Package
and the Final Offering Memorandum, as the case may be). The Common Stock (including the Conversion
Shares) conforms in all material respects to the description thereof contained in the Disclosure
Package and the Final Offering Memorandum. All of the issued and outstanding shares of Common
Stock have been duly authorized and validly issued, are fully paid and nonassessable and have been
issued in compliance with federal and state securities laws. None of the outstanding shares of
Common Stock were issued in violation of any preemptive rights, rights of first refusal or other
similar rights to subscribe for or purchase securities of the Company. There are no authorized or
outstanding options, warrants, preemptive rights, rights of first refusal or other rights to
purchase, or equity or debt securities convertible into or exchangeable or exercisable for, any
capital stock of the Company or any of its subsidiaries other than those accurately described in
the Disclosure Package and the Final Offering Memorandum. The description of the Company’s stock
option, stock bonus and other stock plans or arrangements, and the options or other rights granted
thereunder, set forth or incorporated by reference in the Disclosure Package and the Final Offering
Memorandum accurately and fairly presents and summarizes such plans, arrangements, options and
rights.

(u) Non-Contravention of Existing Instruments; No Further Authorizations or Approvals
Required. Neither the Company nor any of its subsidiaries is (i) in violation or in default (or,
with the giving of notice or lapse of time, would be in default) (“Default”) under its charter or
by-laws, (ii) in Default under any indenture, mortgage, loan or credit agreement, deed of trust,
note, contract, franchise, lease or other agreement, obligation, condition, covenant or instrument
to which the Company or such subsidiary is a party or by which it may be bound (including, without
limitation, the Credit Agreement, dated as of February 1, 2005, among the Company, Alaska
Communications Systems Holdings, Inc., the lenders named therein and Canadian Imperial Bank of
Commerce, acting through its New York agency, as Administrative Agent), or to which any of the
property or assets of the Company or any of its subsidiaries is subject (each, an “Existing
Instrument”) or (iii) in violation of any statute, law, rule, regulation, judgment, order or decree
of any court, regulatory body, administrative agency, governmental body, arbitrator or other
authority having jurisdiction over the Company or such subsidiary or any of its properties, as
applicable, except with respect to clause (ii) only, for such Defaults as would not, individually
or in the aggregate, have a Material Adverse Effect.

The execution, delivery and performance by the Company and each of the Guarantors of the
Operative Documents and the Convertible Note Hedge and Warrant Transaction Documentation and
consummation of the transactions contemplated thereby, by the Disclosure Package and by the Final
Offering Memorandum (i) have been duly authorized by all necessary corporate action and will not
result in any Default under the charter or by-laws of the Company or any such Guarantor, (ii) will
not conflict with or constitute a breach of, or Default or a Debt Repayment Triggering Event (as
defined below) under, or result in the creation or imposition of any lien, charge or encumbrance
upon any property or assets of the Company or any such Guarantor pursuant to, or require the
consent of any other party to, any Existing Instrument and (iii) will not result in any violation
of any statute, law, rule, regulation, judgment, order or decree applicable to the Company or any
such Guarantor of any court, regulatory body, administrative agency, governmental body, arbitrator
or other authority having jurisdiction over the Company or any such Guarantor or any of its or
their properties.

No consent, approval, authorization or other order of, or registration or filing with, any
court or other governmental or regulatory authority or agency is required for the Company’s or the
Guarantors’ execution, delivery and performance of the Operative Documents and the Convertible Note
Hedge and Warrant Transaction Documentation and consummation of the transactions contemplated
thereby, by the Disclosure Package and by the Final Offering Memorandum, except (i) with respect to
the transactions contemplated by the Registration Rights Agreement, as may be required under the
Securities Act, the Trust Indenture Act and the rules and regulations promulgated thereunder, (ii)
such as have been obtained or made by the Company and are in full force and effect under the
Securities Act, applicable state securities or blue sky laws and from the Financial Industry
Regulatory Authority (“FINRA”) and (iii) such as have been obtained or made by the Company under
the rules of the Nasdaq Stock Market LLC.

As used herein, a “Debt Repayment Triggering Event” means any event or condition which gives,
or with the giving of notice or lapse of time would give, the holder of any note, debenture or
other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require
the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or
any of its subsidiaries.

(v) No Stamp or Transfer Taxes. There are no stamp or other issuance or transfer taxes or
duties or other similar fees or charges under federal law or the laws of any state, or any
political subdivision thereof, or any other U.S. or non-U.S. governmental authority required to be
paid in connection with the execution and delivery of this Agreement, the issuance or sale by the
Company of the Notes, upon the issuance of Common Stock upon the conversion of the Notes or upon
the issuance by the Guarantors of the Guarantees.

(w) No Material Actions or Proceedings. Except as otherwise disclosed in the Disclosure
Package and the Final Offering Memorandum, there are no legal or governmental actions, suits or
proceedings pending or, to the best of the Company’s knowledge, threatened against or affecting the
Company or any of its subsidiaries, (i) which has as the subject thereof any officer or director
of, or property owned or leased by, the Company or any of its subsidiaries or (ii) relating to
environmental or employment discrimination matters, where in either such case, (A) there is a
reasonable possibility that such action, suit or proceeding might be determined adversely to the
Company or such subsidiary, or any officer or director of, or property owned or leased by, the
Company or any of its subsidiaries and (B) any such action, suit or proceeding, if so determined
adversely, would reasonably be expected to have a Material Adverse Effect or adversely affect the
consummation of the transactions contemplated by this Agreement.

(x) Labor Matters. No labor problem or dispute with the employees of the Company or any of
its subsidiaries exists or is threatened or imminent, and none of the Company or any of the
Guarantors is aware of any existing, threatened or imminent labor disturbance by the employees of
any of its or its subsidiaries’ principal suppliers, contractors or customers, that could have a
Material Adverse Effect.

(y) Intellectual Property Rights. The Company and its subsidiaries own, possess, license or
have other rights to use, on reasonable terms, all patents, patent applications, trade and service
marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade
secrets, technology, know-how and other intellectual property (collectively, the “Intellectual
Property”) necessary for the conduct of the Company’s business as now conducted or as proposed in
the Disclosure Package and the Final Offering Memorandum to be conducted. Except as set forth in
the Disclosure Package and the Final Offering Memorandum, (a) no party has been granted an
exclusive license to use any portion of such Intellectual Property owned by the Company; (b) there
is no material infringement by third parties of any such Intellectual Property owned by or
exclusively licensed to the Company; (c) there is no pending or threatened action, suit,
proceeding or claim by others challenging the Company’s rights in or to any material Intellectual
Property, and none of the Company or any of the Guarantors is aware of any facts that would form a
reasonable basis for any such claim; (d) there is no pending or threatened action, suit, proceeding
or claim by others challenging the validity or scope of any such Intellectual Property, and none of
the Company or any of the Guarantors is aware of any facts that would form a reasonable basis for
any such claim; and (e) there is no pending or threatened action, suit, proceeding or claim by
others that the Company’s business as now conducted infringes or otherwise violates any patent,
trademark, copyright, trade secret or other proprietary rights of others, and none of the Company
or any of the Guarantors is aware of any other fact that would form a reasonable basis for any such
claim.

(z) All Necessary Permits, etc. The Company and each subsidiary possess such valid and
current licenses, certificates, authorizations or permits issued by the appropriate state, federal
or foreign regulatory agencies or bodies necessary to conduct their respective businesses, and
neither the Company nor any subsidiary has received any notice of proceedings relating to the
revocation or modification of, or non-compliance with, any such license, certificate, authorization
or permit which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or
finding, could have a Material Adverse Effect.

(aa) Title to Properties. The Company and each of its subsidiaries has good and marketable
title to all the properties and assets reflected as owned in the financial statements referred to
in Section 1(p) above or elsewhere in the Disclosure Package and the Final Offering Memorandum, in
each case free and clear of any security interests, mortgages, liens, encumbrances, equities,
claims and other defects, except such as do not materially and adversely affect the value of such
property and do not materially interfere with the use made or proposed to be made of such property
by the Company or such subsidiary. The real property, improvements, equipment and personal
property held under lease by the Company or any subsidiary are held under valid and enforceable
leases, with such exceptions as are not material and do not materially interfere with the use made
or proposed to be made of such real property, improvements, equipment or personal property by the
Company or such subsidiary.

(bb) Tax Law Compliance. The Company and its consolidated subsidiaries have filed all
necessary federal, state, local and foreign income and franchise tax returns in a timely manner and
have paid all taxes required to be paid by any of them and, if due and payable, any related or
similar assessment, fine or penalty levied against any of them, except for any taxes, assessments,
fines or penalties (i) as may be being contested in good faith and by appropriate proceedings or
(ii) the non-payment of which would not result in a Material Adverse Effect. The Company has made
appropriate provisions in the financial statements referred to in Section 1(r) above in respect of
all federal, state, local and foreign income and franchise taxes for all current or prior periods
as to which the tax liability of the Company or any of its consolidated subsidiaries has not been
finally determined.

(cc) Neither Company nor any Guarantor is an “Investment Company”. The Company and each of
the Guarantors has been advised of the rules and requirements under the Investment Company Act
of 1940, as amended, and the rules and regulations promulgated thereunder (the “Investment Company
Act”). None of the Company or any of the Guarantors is, and after receipt of payment for the Notes
and the application of the proceeds thereof as contemplated under the caption “Use of Proceeds” in
the Disclosure Package and the Final Offering Memorandum will be, an “investment company” within
the meaning of the Investment Company Act and will conduct its business in a manner so that it will
not become subject to the Investment Company Act.

(dd) Compliance with Reporting Requirements. The Company is subject to and in full compliance
with the reporting requirements of Section 13 or Section 15(d) of the Exchange Act.

(ee) Insurance. Each of the Company and its subsidiaries are insured by recognized,
financially sound and reputable institutions with policies in such amounts and with such
deductibles and covering such risks as are generally deemed adequate and customary for their
businesses including, but not limited to, policies covering real and personal property owned or
leased by the Company and its subsidiaries against theft, damage, destruction, acts of terrorism or
vandalism and earthquakes. All policies of insurance and fidelity or surety bonds insuring the
Company or any of its subsidiaries or their respective businesses, assets, employees, officers and
directors are in full force and effect; the Company and its subsidiaries are in compliance with the
terms of such policies and instruments in all material respects; and there are no claims by the
Company or any of its subsidiaries under any such policy or instrument as to which any insurance
company is denying liability or defending under a reservation of rights clause; and neither the
Company nor any such subsidiary has been refused any insurance coverage sought or applied for. The
Company has no reason to believe that it or any subsidiary will not be able (i) to renew its
existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage
from similar institutions as may be necessary or appropriate to conduct its business as now
conducted and at a cost that would not have a Material Adverse Effect.

(ff) No Restriction on Dividends or other Distributions. No subsidiary of the Company is
currently prohibited, directly or indirectly, from paying any dividends or other distributions to
the Company or any of the Guarantors, from making any other distribution on such subsidiary’s
capital stock, from repaying to the Company or any Guarantor any loans or advances to such
subsidiary from the Company or such Guarantor or from transferring any of such subsidiary’s
property or assets to the Company or any other subsidiary of the Company, except as described in or
contemplated by the Disclosure Package and the Final Offering Memorandum.

(gg) No Price Stabilization or Manipulation. The Company has not taken and will not take,
directly or indirectly, any action designed to or that might be reasonably expected to cause or
result in stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of the Notes. The Company acknowledges that the Initial Purchasers may engage
in passive market making transactions in the Common Stock on the Nasdaq Stock Market LLC in
accordance with Regulation M under the Exchange Act.

(hh) Related Party Transactions. There are no material business relationships or related
party transactions involving the Company or any subsidiary or any other person that have not been
described in the Disclosure Package or the Final Offering Memorandum.

(ii) No General Solicitation. None of the Company or any of its affiliates (as defined in
Rule 501(b) of Regulation D under the Securities Act (“Regulation D”)), has, directly or through an
agent, engaged in any form of general solicitation or general advertising (as those terms are used
in Regulation D) in connection with the offering of the Notes or the Conversion Shares under the
Securities Act or in any manner involving a public offering within the meaning of Section 4(2) of
the Securities Act; the Company has not entered into any contractual arrangement with respect to
the distribution of the Notes or the Conversion Shares except for this Agreement, and the Company
will not enter into any such arrangement except for the Registration Rights Agreement and as may be
contemplated thereby.

(jj) No Unlawful Contributions or Other Payments. Neither the Company nor any of its
subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or
affiliate of the Company or any of its subsidiaries is aware of or has taken any action, directly
or indirectly, that would result in a violation by such persons of the FCPA, including, without
limitation, making use of the mails or any means or instrumentality of interstate commerce
corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of
any money, or other property, gift, promise to give, or authorization of the giving of anything of
value to any “foreign official” (as such term is defined in the FCPA) or any foreign political
party or official thereof or any candidate for foreign political office, in contravention of the
FCPA and the Company, its subsidiaries and, to the knowledge of the Company and each Guarantor, its
affiliates have conducted their businesses in compliance with the FCPA and have instituted and
maintain policies and procedures designed to ensure, and which are reasonably expected to continue
to ensure, continued compliance therewith. “FCPA” means the Foreign Corrupt Practices Act of 1977,
as amended, and the rules and regulations thereunder.

(kk) No Conflict with Money Laundering Laws. The operations of the Company and its
subsidiaries are and have been conducted at all times in compliance with applicable financial
recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and
regulations thereunder and any related or similar rules, regulations or guidelines issued,
administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”) and
no action, suit or proceeding by or before any court or governmental agency, authority or body or
any arbitrator involving the Company or any of its subsidiaries with respect to the Money
Laundering Laws is pending or, to the best knowledge of the Company or any of the Guarantors,
threatened.

(ll) No Conflict with OFAC Laws. Neither the Company nor any of its subsidiaries nor, to the
knowledge of the Company or any Guarantor, any director, officer, agent, employee or affiliate of
the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by
the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will
not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make
available such proceeds to any subsidiary, joint venture partner or other person or entity, for the
purpose of financing the activities of any person currently subject to any U.S. sanctions
administered by OFAC.

(mm) Compliance with Environmental Laws. Except as otherwise disclosed in the Disclosure
Package and the Final Offering Memorandum, (i) neither the Company nor any of its subsidiaries is
in violation of any federal, state, local or foreign law, regulation, order, permit or other
requirement relating to pollution or protection of human health or the environment (including,
without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or
wildlife, including without limitation, laws and regulations relating to emissions, discharges,
releases or threatened releases of chemicals, pollutants, contaminants, wastes, toxic substances,
hazardous substances, petroleum and petroleum products (collectively, “Materials of Environmental
Concern”), or otherwise relating to the manufacture, processing, distribution, use, treatment,
storage, disposal, transport or handling of Materials of Environmental Concern (collectively,
“Environmental Laws”), which violation includes, but is not limited to, noncompliance with any
permits or other governmental authorizations required for the operation of the business of the
Company or its subsidiaries under applicable Environmental Laws, or noncompliance with the terms
and conditions thereof, nor has the Company or any of its subsidiaries received any written
communication, whether from a governmental authority, citizens group, employee or otherwise, that
alleges that the Company or any of its subsidiaries is in violation of any Environmental Law,
except as would not, individually or in the aggregate, have a Material Adverse Effect; (ii) there
is no claim, action or cause of action filed with a court or governmental authority, no
investigation with respect to which the Company has received written notice, and no written notice
by any person or entity alleging potential liability for investigatory costs, cleanup costs,
governmental responses costs, natural resources damages, property damages, personal injuries,
attorneys’ fees or penalties arising out of, based on or resulting from the presence, or release
into the environment, of any Material of Environmental Concern at any location owned, leased or
operated by the Company or any of its subsidiaries, now or in the past (collectively,
“Environmental Claims”), pending or, to the best of the Company’s and each Guarantor’s knowledge,
threatened against the Company or any of its subsidiaries or any person or entity whose liability
for any Environmental Claim the Company or any of its subsidiaries has retained or assumed either
contractually or by operation of law, except as would not, individually or in the aggregate, have a
Material Adverse Effect; (iii) to the best of the Company’s and each Guarantor’s knowledge, there
are no past, present or anticipated future actions, activities, circumstances, conditions, events
or incidents, including, without limitation, the release, emission, discharge, presence or disposal
of any Material of Environmental Concern, that reasonably could result in a violation of any
Environmental Law, require expenditures to be incurred pursuant to Environmental Law, or form the
basis of a potential Environmental Claim against the Company or any of its subsidiaries or against
any person or entity whose liability for any Environmental Claim the Company or any of its
subsidiaries has retained or assumed either contractually or by operation of law, except as would
not, individually or in the aggregate, have a Material Adverse Effect; and (iv) neither the Company
nor any of its subsidiaries is subject to any pending or threatened proceeding under Environmental
Law to which a governmental authority is a party and which is reasonably likely to result in
monetary sanctions of $100,000 or more.

(nn) Periodic Review of Costs of Environmental Compliance. In the ordinary course of its
business, the Company conducts a periodic review of the effect of Environmental Laws on the
business, operations and properties of the Company and its subsidiaries, in the course of which it
identifies and evaluates associated costs and liabilities (including, without limitation, any
capital or operating expenditures required for cleanup, closure of properties or compliance with
Environmental Laws or any permit, license or approval, any related constraints on operating
activities and any potential liabilities to third parties). On the basis of such review and the
amount of its established reserves, the Company has reasonably concluded that such associated costs
and liabilities would not, individually or in the aggregate, have a Material Adverse Effect.

(oo) ERISA Compliance. None of the following events has occurred or exists: (i) a failure to
fulfill the obligations, if any, under the minimum funding standards of Section 302 of the United
States Employee Retirement Income Security Act of 1974, as amended (“ERISA”), and the regulations
and published interpretations thereunder with respect to a Plan, determined without regard to any
waiver of such obligations or extension of any amortization period; (ii) an audit or investigation
by the Internal Revenue Service, the U.S. Department of Labor, the Pension Benefit Guaranty
Corporation or any other federal or state governmental agency or any foreign regulatory agency with
respect to the employment or compensation of employees by the Company or any of its subsidiaries
that could have a Material Adverse Effect; (iii) any breach of any contractual obligation, or any
violation of law or applicable qualification standards, with respect to the employment or
compensation of employees by the Company or any of its subsidiaries that could have a Material
Adverse Effect. None of the following events has occurred or is reasonably likely to occur: (i) a
material increase in the aggregate amount of contributions required to be made to all Plans in the
current fiscal year of the Company and its subsidiaries compared to the amount of such
contributions made in the Company and its subsidiaries’ most recently completed fiscal year; (ii) a
material increase in the Company and its subsidiaries’ “accumulated post-retirement benefit
obligations” (within the meaning of Statement of Financial Accounting Standards 106) compared to
the amount of such obligations in the Company and its subsidiaries’ most recently completed fiscal
year; (iii) any event or condition giving rise to a liability under Title IV of ERISA that could
have a Material Adverse Effect; or (iv) the filing of a claim by one or more employees or former
employees of the Company or any of its subsidiaries related to its or their employment that could
have a Material Adverse Effect. For purposes of this paragraph, the term “Plan” means a plan
(within the meaning of Section 3(3) of ERISA) subject to Title IV of ERISA with respect to which
the Company or any of its subsidiaries may have any liability.

(pp) Brokers. There is no broker, finder or other party that is entitled to receive from the
Company any brokerage or finder’s fee or other fee or commission as a result of any transactions
contemplated by this Agreement.

(qq) No Outstanding Loans or Other Indebtedness. There are no outstanding loans, advances
(except normal advances for business expenses in the ordinary course of business) or guarantees or
indebtedness by the Company to or for the benefit of any of the officers or directors of the
Company or any of the members of any of their families, except as disclosed in the Disclosure
Package and the Final Offering Memorandum.

(rr) Sarbanes-Oxley Compliance. There is and has been no failure on the part of the Company
and any of the Company’s directors or officers, in their capacities as such, to comply with any
provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection
therewith (the “Sarbanes-Oxley Act”), including Section 402 related to loans and Sections 302 and
906 related to certifications.

(ss) Internal Controls and Procedures. The Company maintains (i) effective internal control
over financial reporting as defined in Rule 13a-15 under the Securities Exchange Act of 1934, as
amended, and (ii) a system of internal accounting controls sufficient to provide reasonable
assurance that (A) transactions are executed in accordance with management’s general or specific
authorizations; (B) transactions are recorded as necessary to permit preparation of financial
statements in conformity with generally accepted accounting principles and to maintain asset
accountability; (C) access to assets is permitted only in accordance with management’s general or
specific authorization; and (D) the recorded accountability for assets is compared with the
existing assets at reasonable intervals and appropriate action is taken with respect to any
differences.

(tt) No Material Weakness in Internal Controls. Except as disclosed in the Disclosure Package
and the Final Offering Memorandum, since the end of the Company’s most recent audited fiscal year,
there has been (i) no material weakness in the Company’s internal control over financial reporting
(whether or not remediated) and (ii) no change in the Company’s internal control over financial
reporting that has materially affected, or is reasonably likely to materially affect, the Company’s
internal control over financial reporting.

(uu) Disclosure Controls. The Company and its subsidiaries maintain an effective system of
“disclosure controls and procedures” (as defined in Rule 13a-15 of the Exchange Act) that is
designed to ensure that information required to be disclosed by the Company in reports that it
files or submits under the Exchange Act is recorded, processed, summarized and reported within the
time periods specified in the Commission’s rules and forms, including controls and procedures
designed to ensure that such information is accumulated and communicated to the Company’s
management as appropriate to allow timely decisions regarding required disclosure. The Company and
its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and
procedures as required by Rule 13a-15 of the Exchange Act.

(vv) Stock Options. With respect to the stock options (the “Stock Options”) granted pursuant
to the stock-based compensation plans of the Company and its subsidiaries (the “Company Stock
Plans”) (i) each Stock Option designated by the Company or the relevant subsidiary of the Company
at the time of grant as an “incentive stock option” under Section 422 of the Internal Revenue Code
of 1986, as amended (the “Code”), so qualifies, (ii) each grant of a Stock Option was duly
authorized no later than the date on which the grant of such Stock Option was by its terms to be
effective (the “Grant Date”) by all necessary corporate action, including, as applicable, approval
by the board of directors of the Company or the relevant subsidiary of the Company (or a duly
constituted and authorized committee thereof) and any required stockholder approval by the
necessary number of votes or written consents, and the award agreement governing such grant (if
any) was duly executed and delivered by each party thereto, (iii) each such grant was made in
accordance with the terms of the Company Stock Plans, the Exchange Act and all other applicable
laws and regulatory rules or requirements, including the rules of Nasdaq Stock Market LLC and any
other exchange on which the securities of the Company or the relevant subsidiary of the Company are
traded, (iv) the per share exercise price of each Stock Option was equal to or greater than the
fair market value of a share of Common Stock on the applicable Grant Date and (v) each such grant
was properly accounted for in accordance with GAAP in the consolidated financial statements
(including the related notes) of the Company and disclosed in the Company’s filings with the
Commission in accordance with the Exchange Act and all other applicable laws, except in the case of
clauses (ii), (iii) or (iv) for such grants that would not, individually or in the aggregate, have
a Material Adverse Effect.

(ww) . Neither the Company nor any of its subsidiaries has knowingly granted, and there is no
and has been no policy or practice of the Company or any of its subsidiaries of granting, Stock
Options prior to, or otherwise coordinating the grant of Stock Options with, the release or other
public announcement of material information regarding the Company or its subsidiaries or their
results of operations or prospects.

(xx) Subsidiaries. The subsidiaries listed on Annex A attached hereto are the only
significant subsidiaries of the Company as defined by Rule 1-02 of Regulation S-X (the
“Subsidiaries”).

(yy) Lending Relationship. Except as disclosed in the Disclosure Package and the Final
Offering Memorandum, the Company (i) does not have any material lending or other relationship with
any bank or lending affiliate of any Initial Purchaser and (ii) does not intend to use any of the
proceeds from the sale of the Notes hereunder to repay any outstanding debt owed to any affiliate
of any Initial Purchaser.

(zz) PORTAL. The Company has been advised by NASDAQ’s PORTAL Market that the Notes have been
designated PORTAL-eligible securities in accordance with the rules and regulations of NASDAQ.

Any certificate signed by an officer of the Company or any Guarantor and delivered to the
Representatives or to counsel for the Initial Purchasers shall be deemed to be a representation and
warranty by the Company or such Guarantor to each Initial Purchaser as to the matters set forth
therein.

Section 2. Purchase, Sale and Delivery of the Notes

(a) The Firm Notes. The Company agrees to issue and sell to the several Initial Purchasers
the Firm Notes upon the terms herein set forth. On the basis of the representations, warranties
and agreements herein contained, and upon the terms but subject to the conditions herein set forth,
the Initial Purchasers agree, severally and not jointly, to purchase from the Company the
respective aggregate principal amount of Firm Notes set forth opposite their names on
Schedule A. The purchase price per Firm Note to be paid by the several Initial Purchasers
to the Company shall be 97% of the aggregate principal amount thereof.

(b) The Closing Date. Delivery of the Firm Notes to be purchased by the Initial Purchasers
and payment therefor shall be made at the offices of Cleary Gottlieb Steen & Hamilton LLP, One
Liberty Plaza, New York, New York 10006 (or such other place as may be agreed to by the Company,
the Guarantors and the Representatives) at 9:00 a.m., New York time, on April 8, 2008, or such
other time and date not later than 1:30 p.m., New York time, on April 22, 2008 as BAS shall
designate by notice to the Company (the time and date of such closing are called the “Closing
Date”).

(c) The Optional Notes; any Subsequent Closing Date. In addition, on the basis of the
representations, warranties and agreements herein contained, and upon the terms but subject to the
conditions herein set forth, the Company and the Guarantors hereby grant an option to the several
Initial Purchasers to purchase, severally and not jointly, up to $18,750,000 aggregate principal
amount of Optional Notes, guaranteed by the Guarantors, from the Company at the same price as the
purchase price per Firm Note to be paid by the Initial Purchasers for the Firm Notes. The option
granted hereunder may be exercised at any time and from time to time upon notice by BAS to the
Company and the Guarantors, which notice may be given at any time within 30 days from the date of
this Agreement. Such notice shall set forth (i) the amount (which shall be an integral multiple of
$1,000 in aggregate principal amount) of Optional Notes as to which the Initial Purchasers are
exercising the option, (ii) the names and denominations in which the Optional Notes are to be
registered and (iii) the time, date and place at which such Optional Notes will be delivered (which
time and date may be simultaneous with, but not earlier than, the Closing Date; and in such case
the term “Closing Date” shall refer to the time and date of delivery of the Firm Notes and the
Optional Notes). Each time and date of delivery, if subsequent to the Closing Date, is called a
“Subsequent Closing Date” and shall be determined by BAS and shall not be earlier than the Closing
Date nor later than 10 business days after delivery of such notice of exercise. If any Optional
Notes are to be purchased, each Initial Purchaser agrees, severally and not jointly, to purchase
the aggregate principal amount of Optional Notes (subject to such adjustments to eliminate
fractional amounts as BAS may determine) that bears the same proportion to the total aggregate
principal amount of Optional Notes to be purchased as the aggregate principal amount of Firm Notes
set forth on Schedule A opposite the name of such Initial Purchaser bears to the total
aggregate principal amount of Firm Notes.

(d) Payment for the Notes. Payment for the Notes shall be made at the Closing Date (and, if
applicable, at any Subsequent Closing Date) by wire transfer of immediately available funds to the
order of the Company.

It is understood that the Representatives has been authorized, for its own account and the
accounts of the several Initial Purchasers, to accept delivery of and receipt for, and make payment
of the purchase price for, the Firm Notes and any Optional Notes the Initial Purchasers have agreed
to purchase. BAS, individually and not as a Representative of the Initial Purchasers, may (but
shall not be obligated to) make payment for any Notes to be purchased by any Initial Purchaser
whose funds shall not have been received by the Representatives by the Closing Date or any
Subsequent Closing Date, as the case may be, for the account of such Initial Purchaser, but any
such payment shall not relieve such Initial Purchaser from any of its obligations under this
Agreement.

(e) Delivery of the Notes. The Company shall deliver, or cause to be delivered, to the
Representatives for the accounts of the several Initial Purchasers the Firm Notes at the Closing
Date, against the irrevocable release of a wire transfer of immediately available funds for the
amount of the purchase price therefor. The Company shall also deliver, or cause to be delivered,
to the Representatives for the accounts of the several Initial Purchasers, the Optional Notes the
Initial Purchasers have agreed to purchase at the Closing Date or any Subsequent Closing Date, as
the case may be, against the irrevocable release of a wire transfer of immediately available funds
for the amount of the purchase price therefor. Delivery of the Firm Notes and the Optional Notes
shall be made through the facilities of The Depository Trust Company unless BAS shall otherwise
instruct. Time shall be of the essence, and delivery at the time and place specified in this
Agreement is a further condition to the obligations of the Initial Purchasers.

Section 3. Covenants of the Company and the Guarantors

Each of the Company and the Guarantors, jointly and severally, covenant and agree with each
Initial Purchaser as follows:

(a) BAS’ Review of Proposed Amendments and Supplements. During such period beginning on the
date hereof and ending on the date of the completion of the resale of the Notes by the Initial
Purchasers (as notified by BAS to the Company), prior to amending or supplementing the Disclosure
Package or the Final Offering Memorandum (other than any filings of any quarterly report on Form
10-Q or any amendment or supplement to such form or to the Company’s Annual Report on Form 10-K for
the year ended December 31, 2007), the Company and the Guarantors shall furnish to BAS for review a
copy of each such proposed amendment or supplement, and the Company shall not print, use or
distribute such proposed amendment or supplement to which BAS reasonably objects.

(b) Amendments and Supplements to the Offering Memorandum and Other Securities Act Matters.
If, at any time prior to the completion of the resale of the Notes by the Initial Purchasers (as
notified by BAS to the Company), any event or development shall occur or condition exist as a
result of which it is necessary to amend or supplement the Disclosure Package or the Final Offering
Memorandum in order that the Disclosure Package or the Final Offering Memorandum will not include
an untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements therein, in the light of the circumstances under which they were made or then
prevailing, as the case may be, not misleading, or if in the opinion of BAS or counsel for the
Initial Purchasers it is otherwise necessary to amend or supplement the Disclosure Package or the
Final Offering Memorandum to comply with law, the Company and each of the Guarantors shall promptly
notify the Initial Purchasers and prepare, subject to Section 3(a) hereof, such amendment or
supplement as may be necessary to correct such untrue statement or omission.

(c) Copies of Disclosure Package and the Offering Memorandum. To the extent not publicly
available, the Company and the Guarantors agree to furnish to the Representatives, without charge,
until the earlier of nine months after the date hereof or the completion of the resale of the Notes
by the Initial Purchasers (as notified by the Initial Purchasers to the Company) as many copies of
the materials contained in the Disclosure Package and the Final Offering Memorandum and any
amendments and supplements thereto as the Representatives may request.

(d) Blue Sky Compliance. The Company and the Guarantors shall cooperate with the
Representatives and counsel for the Initial Purchasers, as the Initial Purchasers may reasonably
request from time to time, to qualify or register the Notes for sale under (or obtain exemptions
from the application of) the state securities or blue sky laws or Canadian provincial securities
laws or other foreign laws of those jurisdictions designated by the Representatives, shall comply
with such laws and shall continue such qualifications, registrations and exemptions in effect so
long as required for the distribution of the Notes. None of the Company or any of the Guarantors
shall be required to qualify as a foreign corporation or to take any action that would subject it
to general service of process in any such jurisdiction where it is not presently qualified or where
it would be subject to taxation as a foreign corporation, other than those arising out of the
offering or sale of the Notes in any jurisdiction where it is not now so subject. The Company and
the Guarantors will advise the Representatives promptly of the suspension of the qualification or
registration of (or any such exemption relating to) the Notes for offering, sale or trading in any
jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event
of the issuance of any order suspending such qualification, registration or exemption, the Company
and the Guarantors shall use its best efforts to obtain the withdrawal thereof at the earliest
possible moment.

(e) Rule 144A Information. For so long as any of the Notes are “restricted securities” within
the meaning of Rule 144(a)(3) under the Securities Act, the Company shall provide to any holder of
the Notes or to any prospective purchaser of the Notes designated by any holder, upon request of
such holder or prospective purchaser, information required to be provided by Rule 144A(d)(4) of the
Securities Act if, at the time of such request, the Company is not subject to the reporting
requirements under Section 13 or 15(d) of the Exchange Act.

(f) Compliance with Securities Law. The Company will comply with all applicable securities
and other laws, rules and regulations, including, without limitation, the Sarbanes-Oxley Act, and
use its best efforts to cause the Company’s directors and officers, in their capacities as such, to
comply with such laws, rules and regulations, including, without limitation, the provisions of the
Sarbanes-Oxley Act.

(g) Legends. Each of the Notes will bear, to the extent applicable, the legend contained in
“Notice to Investors” in the Disclosure Package and the Final Offering Memorandum for the time
period and upon the other terms stated therein.

(h) Written Information Concerning the Offering. Without the prior written consent of BAS,
neither the Company nor any of the Guarantors will give to any prospective purchaser of the Notes
or any other person not in its employ any written information concerning the offering of the Notes
other than the Disclosure Package, the Final Offering Memorandum or any other offering materials
prepared by or with the prior consent of the Representatives.

(i) No General Solicitation. Except following the effectiveness of the Registration
Statement, the Company will not, and will cause its subsidiaries not to, solicit any offer to buy
or offer to sell the Notes by means of any form of general solicitation or general advertising (as
those terms are used in Regulation D under the Securities Act) or in any manner involving a public
offering within the meaning of Section 4(2) of the Securities Act.

(j) No Integration. The Company will not, and will cause its subsidiaries not to, sell, offer
for sale or solicit offers to buy or otherwise negotiate in respect of any “security” (as defined
in the Securities Act) in a transaction that could be integrated with the sale of the Notes in a
manner that would require the registration under the Securities Act of the Notes.

(k) Information to Publishers. Any information provided by the Company or any of the
Guarantors to publishers of publicly available databases about the terms of the Notes and the
Indenture shall include a statement that the Notes have not been registered under the Act and are
subject to restrictions under Rule 144A of the Act.

(l) DTC. The Company and each of the Guarantors will cooperate with the Representatives and
use its best efforts to permit the Notes to be eligible for clearance and settlement through The
Depository Trust Company.

(m) Rule 144 Tolling. During the period of one year after the last Closing Date, the Company
will not, and will not permit any of its “affiliates” (as defined in Rule 144 under the Securities
Act) to, resell any of the Notes that constitute “restricted securities” under Rule 144 that have
been reacquired by any of them.

(n) Use of Proceeds. The Company shall apply the net proceeds from the sale of the Notes sold
by it in the manner described under the caption “Use of Proceeds” in the Disclosure Package and the
Final Offering Memorandum.

(o) Transfer Agent. The Company shall engage and maintain, at its expense, a registrar and
transfer agent for the Common Stock.

(p) Available Conversion Shares. The Company will reserve and keep available at all times,
free of pre-emptive rights, the full number of Conversion Shares.

(q) Conversion Price. Between the date hereof and the Closing Date, none of the Company or
any of the Guarantors will do or authorize any act or thing that would result in an adjustment of
the conversion price.

(r) Company to Provide Interim Financial Statements and Other Information. Prior to the
Closing Date, the Company will furnish the Initial Purchasers, as soon as they have been prepared
by and are available to the Company, a copy of any unaudited interim financial statements of the
Company for any period subsequent to the period covered by the most recent financial statements
appearing in the Disclosure Package and the Final Offering Memorandum.

(s) Agreement Not to Offer or Sell Additional Securities. During the period commencing on the
date hereof and ending on the 90th day following the date of the Final Offering
Memorandum, none of the Company or any of the Guarantors will, without the prior written consent of
BAS (which consent may be withheld at the sole discretion of BAS), directly or indirectly, sell,
offer, contract or grant any option to sell, pledge, transfer or establish an open “put equivalent
position” or liquidate or decrease a “call equivalent position” within the meaning of Rule 16a-1(h)
under the Exchange Act, or otherwise dispose of or transfer (or enter into any transaction that is
designed to, or might reasonably be expected to, result in the disposition of), or announce the
offering of, or file any registration statement under the Securities Act in respect of, any shares
of Common Stock, options or warrants to acquire shares of the Common Stock or securities
exchangeable or exercisable for or convertible into shares of Common Stock (other than as
contemplated by this Agreement with respect to the Notes); provided, however, that
(i) the Company may issue shares of its Common Stock or options to purchase its Common Stock, or
Common Stock upon exercise of options, pursuant to any stock option, stock bonus or other stock
plan or arrangement described in the Disclosure Package and the Final Offering Memorandum, but only
if the holders of such shares, options, or shares issued upon exercise of such options, agree in
writing not to sell, offer, dispose of or otherwise transfer any such shares or options (except
forfeitures of Common Stock or options to purchase Common Stock by the directors and executive
officers subject to the lock-up agreement attached as Exhibit F hereto to satisfy tax
withholding obligations and, in the case of options exercises, payment of exercise price, in
connection with the vesting of equity awards acquired by directors and executive officers pursuant
to equity incentive plans existing and as in effect on the date of this Agreement will be
permitted, provided that the number of shares sold for consideration on the open market or
to any third party by all of the officers and directors of the Company who are subject to the
lock-up agreement does not in the aggregate exceed 200,000 shares of Common Stock) during such
90-day period without the prior written consent of BAS (which consent may be withheld at the sole
discretion of the BAS) and (ii) the foregoing shall not apply to the entry into the transactions
contemplated by the Convertible Note Hedge and Warrant Transaction Documentation.

(t) Future Reports to Stockholders. The Company will make available to its stockholders as
soon as practicable after the end of each fiscal year an annual report (including a balance sheet
and statements of income, stockholders’ equity and cash flows of the Company and its consolidated
subsidiaries certified by independent public accountants) and, as soon as practicable after the end
of each of the first three quarters of each fiscal year (beginning with the fiscal quarter ending
after the date of the Final Offering Memorandum), to make available to its stockholders
consolidated summary financial information of the Company and its subsidiaries for such quarter in
reasonable detail.

(u) Future Reports to the Representatives. During the period of five years hereafter, the
Company will furnish to the Representatives (i) as soon as practicable after the end of each fiscal
year, copies of the Annual Report of the Company containing the balance sheet of the Company as of
the close of such fiscal year and statements of income, stockholders’ equity and cash flows for the
year then ended and the opinion thereon of the Company’s independent public or certified public
accountants; (ii) as soon as practicable after the filing thereof, copies of each proxy statement,
Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other
report filed by the Company with the Commission, FINRA or any securities exchange; and (iii) as
soon as available, copies of any report or communication of the Company mailed generally to holders
of its capital stock.

(v) Investment Limitation. The Company shall not invest or otherwise use the proceeds
received by the Company from its sale of the Notes in such a manner as would require the Company or
any of its subsidiaries to register as an investment company under the Investment Company Act.

(w) No Manipulation of Price. None of the Company or any of the Guarantors will take,
directly or indirectly, any action designed to cause or result in, or that has constituted or might
reasonably be expected to constitute, under the Exchange Act or otherwise, the stabilization or
manipulation of the price of any securities of the Company to facilitate the sale or resale of the
Notes.

(x) Existing Lock-Up Agreements. The Company will enforce all existing agreements between the
Company and any of its security holders that prohibit the sale, transfer, assignment, pledge or
hypothecation of any of the Company’s securities in connection with the Company’s initial public
offering. In addition, the Company will direct the transfer agent to place stop transfer
restrictions upon any such securities of the Company that are bound by such existing “lock-up”
agreements for the duration of the periods contemplated in such agreements.

(y) New Lock-Up Agreements. The Company will enforce all agreements between the Company and
any of its security holders to be entered into pursuant to this agreement that prohibit the sale,
transfer, assignment, pledge or hypothecation of any of the Company’s securities. In addition, the
Company will direct the transfer agent to place stop transfer restrictions upon any such securities
of the Company that are bound by such “lock-up” agreements for the duration of the periods
contemplated in such agreements.

(z) Final Term Sheet. The Company will prepare a final term sheet, containing solely a
description of the Notes and the offering thereof, in the form approved by you and attached as
Schedule B hereto (the “Final Term Sheet”).

Section 4. Payment of Expenses

Each of the Company and the Guarantors, jointly and severally, agrees to pay all costs, fees
and expenses incurred in connection with the performance of its obligations hereunder and in
connection with the transactions contemplated hereby, including without limitation (i) all expenses
incident to the issuance and delivery of the Notes (including all printing and engraving costs),
(ii) all fees and expenses of the Trustee under the Indenture, (iii) all necessary issue, transfer
and other stamp taxes in connection with the issuance and sale of the Notes to the Initial
Purchasers, (iv) all fees and expenses of the Company’s and the Guarantors’ counsel, independent
public or certified public accountants and other advisors, (v) all costs and expenses incurred in
connection with the preparation, printing, shipping and distribution of the materials contained in
the Disclosure Package and the Final Offering Memorandum, all amendments and supplements thereto
and this Agreement, (vi) all filing fees, attorneys’ fees and expenses incurred by the Company, the
Guarantors or the Initial Purchasers in connection with qualifying or registering (or obtaining
exemptions from the qualification or registration of) all or any part of the Notes for offer and
sale under the state securities or blue sky laws or the provincial securities laws of Canada, and,
if requested by the Representatives, preparing and printing a “Blue Sky Survey” or memorandum, and
any supplements thereto, advising the Initial Purchasers of such qualifications, registrations and
exemptions, (vii)  the expenses of the Company, the Guarantors and the Initial Purchasers in
connection with the marketing and offering of the Notes, including all transportation and other
expenses incurred in connection with presentations to prospective purchasers of the Notes, except
that the Company and the Guarantors, on the one hand, and the Initial Purchasers, on the other
hand, will each pay 50% of the cost of privately chartered airplanes used for such purposes,
(viii) the fees and expenses associated with listing the Conversion Shares on the Nasdaq Stock
Market LLC and (ix) all expenses and fees in connection with admitting the Notes for trading in the
PORTAL Market. Except as provided in this Section 4, Section 7 and Section 11 hereof, the Initial
Purchasers shall pay their own expenses, including the fees and disbursements of their counsel.

Section 5. Conditions of the Obligations of the Initial Purchasers

The obligations of the several Initial Purchasers to purchase and pay for the Notes as
provided herein on the Closing Date and, with respect to the Optional Notes, any Subsequent Closing
Date, shall be subject to the accuracy of the representations and warranties on the part of the
Company set forth in Section 1 hereof as of the date hereof and as of the Closing Date as though
then made and, with respect to the Optional Notes, as of any Subsequent Closing Date as though then
made, to the accuracy of the statements of the Company made in any certificates pursuant to the
provisions hereof, to the timely performance by the Company and the Guarantors of its covenants and
other obligations hereunder, and to each of the following additional conditions:

(a) Accountants’ Comfort Letter. On the date hereof, the Representatives shall have received
from KPMG LLP, independent public accountants for the Company, a letter dated the date hereof
addressed to the Initial Purchasers, the form of which is attached as Exhibit A.

(b) No Material Adverse Change or Ratings Agency Change. For the period from and after the
date of this Agreement and prior to the Closing Date and, with respect to the Optional Notes, any
Subsequent Closing Date:

(i) in the judgment of BAS, there shall not have occurred any Material Adverse Change;

(ii) there shall not have been any change or decrease specified in the letter or
letters referred to in paragraph (a) of this Section 5 which is, in the sole judgment of
BAS, so material and adverse as to make it impractical or inadvisable to proceed with the
offering or delivery of the Notes as contemplated by the Disclosure Package and the Final
Offering Memorandum; and

(iii) there shall not have occurred any downgrading, nor shall any notice have been
given of any intended or potential downgrading or of any review for a possible change that
does not indicate the direction of the possible change, in the rating accorded any
securities of the Company or any of its subsidiaries by any “nationally recognized
statistical rating organization” as such term is defined for purposes of Rule 436(g)(2)
under the Securities Act.

(c) Opinions of Counsel for the Company and the Guarantors. On each of the Closing Date and
any Subsequent Closing Date, the Representatives shall have received the favorable opinion of (i)
Sidley Austin LLP, counsel for the Company and the Guarantors, the form of which is attached as
Exhibit B, (ii) Leonard Steinberg, General Counsel of the Company and the Guarantors, the
form of which is attached as Exhibit C, (iii) Birch Horton Bittner & Cherot, local Alaska
counsel for the Company and the Guarantors, the form of which is attached as Exhibit D and
(iv) Latham & Watkins LLP, special regulatory counsel for the Company and the Guarantors, the form
of which is attached as Exhibit E, each dated as of such Closing Date or Subsequent Closing
Date.

(d) Opinion of Counsel for the Initial Purchasers. On the Closing Date and any Subsequent
Closing Date, the Representatives shall have received the favorable opinion of Cleary Gottlieb
Steen & Hamilton LLP, counsel for the Initial Purchasers, dated as of such Closing Date or
Subsequent Closing Date, in form and substance satisfactory to, and addressed to, the
Representatives, with respect to the issuance and sale of the Notes, the Disclosure Package, the
Final Offering Memorandum and other related matters as the Representatives may reasonably require,
and the Company shall have furnished to such counsel such documents as they request for the purpose
of enabling them to pass upon such matters.

(e) Officers’ Certificate. On the Closing Date and any Subsequent Closing Date, the
Representatives shall have received a written certificate executed by the Chairman of the Board,
Chief Executive Officer or President of each of the Company and the Guarantors and the Chief
Financial Officer or Chief Accounting Officer of each of the Company and the Guarantors, dated as
of such Closing Date or Subsequent Closing Date, to the effect that the signers of such certificate
have carefully examined the Disclosure Package and the Final Offering Memorandum, any amendments or
supplements thereto and this Agreement, to the effect set forth in subsection (b)(iii) of this
Section 5, and further to the effect that:

(i) for the period from and after the date of this Agreement and prior to such Closing
Date or Subsequent Closing Date, as the case may be, there has not occurred any Material
Adverse Change with respect to the Company or such Guarantor;

(ii) the representations and warranties of the Company and the Guarantors set forth in
Section 1 of this Agreement are true and correct on and as of such Closing Date or
Subsequent Closing Date with the same force and effect as though expressly made on and as
of such Closing Date or such Subsequent Closing Date, as the case may be; and

(iii) the Company and each Guarantor has complied with all the agreements hereunder
and satisfied all the conditions on its part to be performed or satisfied hereunder at or
prior to such Closing Date or Subsequent Closing Date, as the case may be.

(f) Bring-down Comfort Letter. On the Closing Date and any Subsequent Closing Date, the
Representatives shall have received from KPMG LLP, independent public accountants for the Company,
a letter dated such date, in form and substance satisfactory to the Representatives, to the effect
that they reaffirm the statements made in the letter furnished by them pursuant to subsection (a)
of this Section 5, except that the specified date referred to therein for the carrying out of
procedures shall be no more than three business days prior to such Closing Date or Subsequent
Closing Date.

(g) Registration Rights Agreement. The Company and the Initial Purchasers shall have executed
and delivered the Registration Rights Agreement (in form and substance satisfactory to the Initial
Purchasers), and the Registration Rights Agreement shall be in full force and effect.

(h) Lock-Up Agreement from Certain Securityholders of the Company. On or prior to the date
hereof, the Company and the Guarantors shall have furnished to the Representatives an agreement in
the form of Exhibit F hereto from each director and executive officer of the company listed
in Schedule E, and such agreement shall be in full force and effect on each of the Closing
Date and any Subsequent Closing Date.

(i) PORTAL Designation. The Notes shall have been designated PORTAL-eligible securities
in accordance with the rules and regulations of NASDAQ.

(j) Listing. The Company and the Guarantors shall have caused the Conversion Shares to be
approved for listing, subject to notice of issuance, on the Nasdaq Stock Market LLC.

(k) Additional Documents. On or before each of the Closing Date and any Subsequent Closing
Date, the Representatives and counsel for the Initial Purchasers shall have received such
information, documents and opinions as they may reasonably require for the purposes of enabling
them to pass upon the issuance and sale of the Notes as contemplated herein, or in order to
evidence the accuracy of any of the representations and warranties, or the satisfaction of any of
the conditions or agreements, herein contained.

If any condition specified in this Section 5 is not satisfied when and as required to be
satisfied, this Agreement may be terminated by BAS by notice to the Company and the Guarantors at
any time on or prior to the Closing Date and, with respect to the Optional Notes, at any time prior
to the applicable Subsequent Closing Date, which termination shall be without liability on the part
of any party to any other party, except that Section 4, Section 7, Section 8, Section 9 and Section
14 shall at all times be effective and shall survive such termination.

Section 6. Representations, Warranties and Agreements of Initial Purchasers

Each of the Initial Purchasers represents and warrants that it is a “qualified institutional
buyer”, as defined in Rule 144A of the Securities Act. Each Initial Purchaser agrees with the
Company that:

(a) it has not offered or sold, and will not offer or sell, any Notes within the United States
or to, or for the account or benefit of, U.S. persons (x) as part of their distribution at any time
or (y) otherwise until one year after the later of the commencement of the offering and the date of
closing of the offering except to those it reasonably believes to be “qualified institutional
buyers” (as defined in Rule 144A under the Act);

(b) neither it nor any person acting on its behalf has made or will make offers or sales of
the Notes in the United States by means of any form of general solicitation or general advertising
(within the meaning of Regulation D) in the United States;

(c) in connection with each sale pursuant to Section 6(a)(i), it has taken or will take
reasonable steps to ensure that the purchaser of such Notes is aware that such sale is being made
in reliance on Rule 144A;

(d) any information provided by the Initial Purchasers to publishers of publicly available
databases about the terms of the Notes and the Indenture shall include a statement that the Notes
have not been registered under the Act and are subject to restrictions under Rule 144A under the
Act;

(e) it acknowledges that additional restrictions on the offer and sale of the Notes and the
Common Stock issuable upon conversion thereof are described in the Disclosure Package and the Final
Offering Memorandum.

Section 7. Reimbursement of Initial Purchasers’ Expenses

If this Agreement is terminated pursuant to Section 5 or Section 11, or if the sale to the
Initial Purchasers of the Notes on the Closing Date or any Subsequent Closing Date is not
consummated because of any refusal, inability or failure on the part of the Company or any
Guarantor to perform any agreement herein or to comply with any provision hereof, each of the
Company and the Guarantors, jointly and severally, agrees to reimburse the Representatives and the
other Initial Purchasers (or such Initial Purchasers as have terminated this Agreement with respect
to themselves), severally, upon demand for all out-of-pocket expenses that shall have been
reasonably incurred by the Representatives and the Initial Purchasers in connection with the
proposed purchase and the offering and sale of the Notes, including but not limited to fees and
disbursements of counsel, printing expenses, travel expenses, postage, facsimile and telephone
charges.

Section 8. Indemnification

(a) Indemnification of the Initial Purchasers. Each of the Company and the Guarantors,
jointly and severally, agrees to indemnify and hold harmless each Initial Purchaser, its directors,
officers, employees and agents, and each person, if any, who controls any Initial Purchaser within
the meaning of the Securities Act or the Exchange Act against any loss, claim, damage, liability or
expense, as incurred, to which such Initial Purchaser, director, officer, employee, agent or
controlling person may become subject, insofar as such loss, claim, damage, liability or expense
(or actions in respect thereof as contemplated below) arises out of or is based upon any untrue
statement or alleged untrue statement of a material fact contained in the Disclosure Package, the
Final Offering Memorandum, the information contained in the Final Term Sheet or any other written
information used by or on behalf of the Company in connection with the offer or sale of the Notes
(or any amendment or supplement to the foregoing), or the omission or alleged omission therefrom of
a material fact, in each case, necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading, and to reimburse each Initial
Purchaser, its officers, directors, employees, agents and each such controlling person for any and
all expenses (including the fees and disbursements of counsel chosen by BAS) as such expenses are
reasonably incurred by such Initial Purchaser, or its officers, directors, employees, agents or
such controlling person in connection with investigating, defending, settling, compromising or
paying any such loss, claim, damage, liability, expense or action; provided,
however, that the foregoing indemnity agreement shall not apply to any loss, claim, damage,
liability or expense to the extent, but only to the extent, arising out of or based upon any untrue
statement or alleged untrue statement or omission or alleged omission based upon and in conformity
with written information furnished to the Company and the Guarantors by any Initial Purchaser
through BAS expressly for use in the Disclosure Package, the Final Offering Memorandum, the Final
Term Sheet or any other written information used by or on behalf of the Company in connection with
the offer or sale of the Notes (or any amendment or supplement thereto), it being understood and
agreed that the only such information furnished by any Initial Purchaser consists of the
information described as such in Section 8(b) hereof. The indemnity agreement set forth in this
Section 8(a) shall be in addition to any liabilities that the Company and the Guarantors may
otherwise have.

(b) Indemnification of the Company, the Guarantors and their Directors and Officers. Each
Initial Purchaser agrees, severally and not jointly, to indemnify and hold harmless the Company and
each Guarantor, each of their respective directors, each of their respective officers and each
person, if any, who controls the Company or any such Guarantor within the meaning of the Securities
Act or the Exchange Act, against any loss, claim, damage, liability or expense, as incurred, to
which the Company, any such Guarantor, or any such director, officer or controlling person may
become subject, insofar as such loss, claim, damage, liability or expense (or actions in respect
thereof as contemplated below) arises out of or is based upon any untrue or alleged untrue
statement of a material fact contained in the Disclosure Package, the Final Offering Memorandum,
the information contained in the Final Term Sheet or any other written information used by or on
behalf of the Company and the Guarantors in connection with the offer or sale of the Notes (or any
amendment or supplement thereto), or arises out of or is based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the
statements therein not misleading, in each case to the extent, and only to the extent, that such
untrue statement or alleged untrue statement or omission or alleged omission was made in the
Disclosure Package, the Final Offering Memorandum, the Final Term Sheet or any other written
information used by or on behalf of the Company and the Guarantors in connection with the offer or
sale of the Notes (or any amendment or supplement thereto), in reliance upon and in conformity with
written information furnished to the Company and the Guarantors by BAS expressly for use therein;
and to reimburse the Company, any such Guarantor, or any such director, officer or controlling
person for any legal and other expense reasonably incurred by the Company, any such Guarantor, or
any such director, officer or controlling person in connection with investigating, defending,
settling, compromising or paying any such loss, claim, damage, liability, expense or action. Each
of the Company and the Guarantors hereby acknowledges that the only information that the Initial
Purchasers have furnished to the Company and the Guarantors expressly for use in the Disclosure
Package, the Final Offering Memorandum, the Final Term Sheet or any other written information used
by or on behalf of the Company in connection with the offer or sale of the Notes (or any amendment
or supplement thereto) are the statements set forth in Schedule C. The indemnity agreement
set forth in this Section 8(b) shall be in addition to any liabilities that each Initial Purchaser
may otherwise have.

(c) Notifications and Other Indemnification Procedures. Promptly after receipt by an
indemnified party under this Section 8 of notice of the commencement of any action, such
indemnified party will, if a claim in respect thereof is to be made against an indemnifying party
under this Section 8, notify the indemnifying party in writing of the commencement thereof, but the
failure to so notify the indemnifying party (i) will not relieve it from liability under paragraph
(a) or (b) above unless and to the extent it did not otherwise learn of such action and such
failure results in the forfeiture by the indemnifying party of substantial rights and defenses
and (ii) will not, in any event, relieve the indemnifying party from any obligations to any
indemnified party other than the indemnification obligation provided in paragraph (a) or (b) above.
In case any such action is brought against any indemnified party and such indemnified party seeks
or intends to seek indemnity from an indemnifying party, the indemnifying party will be entitled to
participate in, and, to the extent that it shall elect, jointly with all other indemnifying parties
similarly notified, by written notice delivered to the indemnified party promptly after receiving
the aforesaid notice from such indemnified party, to assume the defense thereof with counsel
satisfactory to such indemnified party; provided, however, if the defendants in any
such action include both the indemnified party and the indemnifying party and the indemnified party
shall have reasonably concluded that a conflict may arise between the positions of the indemnifying
party and the indemnified party in conducting the defense of any such action or that there may be
legal defenses available to it and/or other indemnified parties that are different from or
additional to those available to the indemnifying party, the indemnified party or parties shall
have the right to select separate counsel to assume such legal defenses and to otherwise
participate in the defense of such action on behalf of such indemnified party or parties. Upon
receipt of notice from the indemnifying party to such indemnified party of such indemnifying
party’s election so to assume the defense of such action and approval by the indemnified party of
counsel, the indemnifying party will not be liable to such indemnified party under this Section 8
for any legal or other expenses subsequently incurred by such indemnified party in connection with
the defense thereof unless (i) the indemnified party shall have employed separate counsel in
accordance with the proviso to the preceding sentence (it being understood, however, that the
indemnifying party shall not be liable for the expenses of more than one separate counsel (other
than local counsel), reasonably approved by the indemnifying party (or by BAS in the case of
Section 8(b)), representing the indemnified parties who are parties to such action) or (ii) the
indemnifying party shall not have employed counsel satisfactory to the indemnified party to
represent the indemnified party within a reasonable time after notice of commencement of the
action, in each of which cases the fees and expenses of counsel shall be at the expense of the
indemnifying party.

(d) Settlements. The indemnifying party under this Section 8 shall not be liable for any
settlement of any proceeding effected without its written consent, which shall not be withheld
unreasonably, but if settled with such consent or if there is a final judgment for the plaintiff,
the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage,
liability or expense by reason of such settlement or judgment. Notwithstanding the foregoing
sentence, if at any time an indemnified party shall have requested an indemnifying party to
reimburse the indemnified party for fees and expenses of counsel as contemplated by Section 8(c)
hereof, the indemnifying party agrees that it shall be liable for any settlement of any proceeding
effected without its written consent if (i) such settlement is entered into more than 30 days after
receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall
not have reimbursed the indemnified party in accordance with such request prior to the date of such
settlement. No indemnifying party shall, without the prior written consent of the indemnified
party, effect any settlement, compromise or consent to the entry of judgment in any pending or
threatened action, suit or proceeding in respect of which any indemnified party is or could have
been a party and indemnity was or could have been sought hereunder by such indemnified party,
unless such settlement, compromise or consent (x) includes an unconditional release of such
indemnified party from all liability on claims that are the subject matter of such action, suit or
proceeding and (y) does not include a statement as to or an admission of fault, culpability or a
failure to act by or on behalf of any indemnified party.

Section 9. Contribution

If the indemnification provided for in Section 8 is for any reason unavailable to or otherwise
insufficient to hold harmless an indemnified party in respect of any losses, claims, damages,
liabilities or expenses referred to therein, then each indemnifying party shall contribute to the
aggregate amount paid or payable by such indemnified party, as incurred, as a result of any losses,
claims, damages, liabilities or expenses referred to therein (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company and the Guarantors, on the one
hand, and the Initial Purchasers, on the other hand, from the offering of the Notes pursuant to
this Agreement or (ii) if the allocation provided by clause (i) above is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the relative benefits
referred to in clause (i) above but also the relative fault of the Company and the Guarantors, on
the one hand, and the Initial Purchasers, on the other hand, in connection with the untrue
statements or omissions or alleged untrue statements or alleged omissions which resulted in such
losses, claims, damages, liabilities or expenses, as well as any other relevant equitable
considerations. The relative benefits received by the Company and the Guarantors, on the one hand,
and the Initial Purchasers, on the other hand, in connection with the offering of the Notes
pursuant to this Agreement shall be deemed to be in the same respective proportions as the total
net proceeds from the offering of the Notes pursuant to this Agreement (before deducting expenses)
received by the Company and the Guarantors, and the total purchase discount received by the Initial
Purchasers bear to the aggregate initial offering price of the Notes. The relative fault of the
Company and the Guarantors, on the one hand, and the Initial Purchasers, on the other hand, shall
be determined by reference to, among other things, whether any such untrue or alleged untrue
statement of a material fact or omission or alleged omission to state a material fact relates to
information supplied by the Company and the Guarantors, on the one hand, or the Initial Purchasers,
on the other hand, and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission.

The amount paid or payable by a party as a result of the losses, claims, damages, liabilities
and expenses referred to above shall be deemed to include, subject to the limitations set forth in
Section 8(c), any legal or other fees or expenses reasonably incurred by such party in connection
with investigating or defending any action or claim.

The Company and the Guarantors, on the one hand, and the Initial Purchasers, on the other
hand, agree that it would not be just and equitable if contribution pursuant to this Section 9 were
determined by pro rata allocation (even if the Initial Purchasers were treated as one entity for
such purpose) or by any other method of allocation that does not take account of the equitable
considerations referred to in this Section 9.

Notwithstanding the provisions of this Section 9, no Initial Purchaser shall be required to
contribute any amount in excess of the purchase discount or commission received by such Initial
Purchaser in connection with the Notes purchased by it hereunder. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. The Initial
Purchasers’ obligations to contribute pursuant to this Section 9 are several, and not joint, in
proportion to their respective purchasing commitments as set forth opposite their names in
Schedule A. For purposes of this Section 9, each director, officer, employee and agent of
an Initial Purchaser and each person, if any, who controls an Initial Purchaser within the meaning
of the Securities Act and the Exchange Act shall have the same rights to contribution as such
Initial Purchaser, and each director of the Company or any Guarantor, each officer of the Company
or any Guarantor, and each person, if any, who controls the Company or any Guarantor within the
meaning of the Securities Act or the Exchange Act shall have the same rights to contribution as the
Company or any such Guarantor.

Section 10. Default of One or More of the Several Initial Purchasers

If, on the Closing Date or a Subsequent Closing Date, as the case may be, any one or more of
the several Initial Purchasers shall fail or refuse to purchase Notes that it or they have agreed
to purchase hereunder on such date, and the aggregate principal amount of Notes which such
defaulting Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase does
not exceed 10% of the aggregate principal amount of the Notes to be purchased on such date, the
other Initial Purchasers shall be obligated, severally, in the proportions that the aggregate
principal amount of Firm Notes set forth opposite their respective names on Schedule A
bears to the aggregate principal amount of Firm Notes set forth opposite the names of all such
non-defaulting Initial Purchasers, or in such other proportions as may be specified by BAS with the
consent of the non-defaulting Initial Purchasers, to purchase the Notes which such defaulting
Initial Purchaser or Initial Purchasers agreed but failed or refused to purchase on such date. If,
on the Closing Date or a Subsequent Closing Date, as the case may be, any one or more of the
Initial Purchasers shall fail or refuse to purchase Notes and the aggregate principal amount of
Notes with respect to which such default occurs exceeds 10% of the aggregate principal amount of
Notes to be purchased on such date, and arrangements satisfactory to BAS, one the one hand, and the
Company and the Guarantors, on the other hand, for the purchase of such Notes are not made within
48 hours after such default, this Agreement shall terminate without liability of any party to any
other party except that the provisions of Section 4, Section 8 and Section 9 shall at all times be
effective and shall survive such termination. In any such case either BAS, on the one hand, or the
Company and the Guarantors, on the other hand, shall have the right to postpone the Closing Date or
a Subsequent Closing Date, as the case may be, but in no event for longer than seven days in order
that the required changes, if any, to the Final Offering Memorandum or any other documents or
arrangements may be effected.

As used in this Agreement, the term “Initial Purchaser” shall be deemed to include any person
substituted for a defaulting Initial Purchaser under this Section 10. Any action taken under this
Section 10 shall not relieve any defaulting Initial Purchaser from liability in respect of any
default of such Initial Purchaser under this Agreement.

Section 11. Termination of this Agreement

Prior to the Closing Date and, with respect to the Optional Notes, any Subsequent Closing
Date, this Agreement may be terminated by BAS by notice given to the Company and the Guarantors if
at any time (i) trading or quotation in any of the Company’s or any Guarantor’s securities shall
have been suspended or limited by the Commission or by the Nasdaq Stock Market LLC, or trading in
securities generally on the New York Stock Exchange or the Nasdaq Stock Market LLC shall have been
suspended or limited, or minimum or maximum prices shall have been generally established by the
Commission or FINRA or on either such stock exchange; (ii) a general banking moratorium shall have
been declared by federal or New York authorities or a material disruption in commercial banking or
securities settlement or clearance services in the United States has occurred; or (iii) there shall
have occurred any outbreak or escalation of national or international hostilities or declaration of
a national emergency or war by the United States or any crisis or calamity, or any change in the
United States or international financial markets, or any substantial change or development
involving a prospective substantial change in United States’ or international political, financial
or economic conditions, as in the judgment of BAS is material and adverse and makes it
impracticable or inadvisable to market the Notes in the manner and on the terms described in the
Disclosure Package and the Final Offering Memorandum or to enforce contracts for the sale of
securities. Any termination pursuant to this Section 11 shall be without liability on the part of
(a) the Company or any Guarantor to any Initial Purchaser, except that the Company and the
Guarantors shall be obligated to reimburse the expenses of the Representatives and the Initial
Purchasers pursuant to Sections 4 and 7 hereof or (b) any Initial Purchaser to the Company or any
Guarantor.

Section 12. No Advisory or Fiduciary Responsibility

Each of the Company and Guarantors acknowledges and agrees that: (i) the purchase and sale of
the Notes pursuant to this Agreement, including the determination of the offering price of the
Notes and any related discounts and commissions, is an arm’s-length commercial transaction between
the Company and the Guarantors, on the one hand, and the several Initial Purchasers, on the other
hand, and the Company and the Guarantors are capable of evaluating and understanding and
understands and accepts the terms, risks and conditions of the transactions contemplated by this
Agreement; (ii) in connection with each transaction contemplated hereby and the process leading to
such transaction each Initial Purchaser is and has been acting solely as a principal and is not the
financial advisor, agent or fiduciary of the Company, the Guarantors or their respective
affiliates, stockholders, creditors or employees or any other party; (iii) no Initial Purchaser has
assumed or will assume an advisory, agency or fiduciary responsibility in favor of the Company or
any Guarantor with respect to any of the transactions contemplated hereby or the process leading
thereto (irrespective of whether such Initial Purchaser has advised or is currently advising the
Company or any Guarantor on other matters) and no Initial Purchaser has any obligation to the
Company or any Guarantor with respect to the offering contemplated hereby except the obligations
expressly set forth in this Agreement; (iv) the several Initial Purchasers and their respective
affiliates may be engaged in a broad range of transactions that involve interests that differ from
those of the Company and the Guarantors and that the several Initial Purchasers have no obligation
to disclose any of such interests by virtue of any advisory, agency or fiduciary relationship; and
(v) the Initial Purchasers have not provided any legal, accounting, regulatory or tax advice with
respect to the offering contemplated hereby and each of the Company and the Guarantors has
consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed
appropriate.

This Agreement supersedes all prior agreements and understandings (whether written or oral)
among the Company, the Guarantors and the several Initial Purchasers, or any of them, with respect
to the subject matter hereof. Each of the Company and the Guarantors hereby waives and releases,
to the fullest extent permitted by law, any claims that the Company or any Guarantor may have
against the several Initial Purchasers with respect to any breach or alleged breach of agency or
fiduciary duty.

Section 13. Research Analyst Independence

Each of the Company and the Guarantors acknowledges that the Initial Purchasers’ research
analysts and research departments are required to be independent from their respective investment
banking divisions and are subject to certain regulations and internal policies, and that such
Initial Purchasers’ research analysts may hold views and make statements or investment
recommendations and/or publish research reports with respect to the Company, the Guarantors and/or
the offering that differ from the views of their respective investment banking divisions. Each of
the Company and the Guarantors hereby waives and releases, to the fullest extent permitted by law,
any claims that the Company or any Guarantor may have against the Initial Purchasers with respect
to any conflict of interest that may arise from the fact that the views expressed by their
independent research analysts and research departments may be different from or inconsistent with
the views or advise communicated to the Company or any Guarantor by such Initial Purchasers’
investment banking divisions. Each of the Company and the Guarantors acknowledges that each of the
Initial Purchasers is a full service securities firm and as such from time to time, subject to
applicable securities laws, may effect transactions for its own account or the account of its
customers and hold long or short positions in debt or equity securities of the companies that may
be the subject of the transactions contemplated by this Agreement.

Section 14. Representations and Indemnities to Survive Delivery

The respective indemnities, agreements, representations, warranties and other statements of
the Company and each Guarantor, of their respective officers and of the several Initial Purchasers
set forth in or made pursuant to this Agreement (i) will remain operative and in full force and
effect, regardless of any (A) investigation, or statement as to the results thereof, made by or on
behalf of any Initial Purchaser, the officers or employees of any Initial Purchaser, or any person
controlling the Initial Purchaser, the Company, any Guarantor, the officers or employees of the
Company or any Guarantor, or any person controlling the Company or any Guarantor, as the case may
be or (B) acceptance of the Notes and payment for them hereunder and (ii) will survive delivery of
and payment for the Notes sold hereunder and any termination of this Agreement.

Section 15. Notices

All communications hereunder shall be in writing and shall be mailed, hand delivered or
telecopied and confirmed to the parties hereto as follows:

	 	 	 	If to BAS:

Banc of America Securities LLC

9 West 57th Street

New York, NY 10019

Facsimile: 212-933-2217

Attention: Syndicate Department

	 	 	 	with a copy to:

Banc of America Securities LLC

9 West 57th Street

New York, NY 10019

Facsimile: 212-457-3745

Attention: ECM Legal

	 	 	 	If to Oppenheimer:

Oppenheimer & Co. Inc.

300 Madison Avenue

New York, NY 10017

Facsimile: 212-667-6140

Attention: Amanda Cenci

	 	 	 	If to the Company or any Guarantor:

Alaska Communications Systems Group, Inc.

600 Telephone Avenue

Anchorage, Alaska 99503-6091

Facsimile: 907-297-3153

Attention: Leonard Steinberg

	 	 	 	with a Copy to:

Sidley Austin LLP

787 Seventh Avenue

New York, NY 10019

Facsimile: 212-839-5599

Attn: Samir A. Gandhi

Any party hereto may change the address for receipt of communications by giving written notice
to the others.

Section 16. Successors and Assigns

This Agreement will inure to the benefit of and be binding upon the parties hereto, including
any substitute Initial Purchasers pursuant to Section 10 hereof, and to the benefit of (i) the
Company and the Guarantors, their respective directors, any person who controls the Company or any
Guarantor within the meaning of the Securities Act or the Exchange Act, (ii) the Initial
Purchasers, the officers, directors, employees and agents of the Initial Purchasers and each
person, if any, who controls any Initial Purchaser within the meaning of the Securities Act or the
Exchange Act and (iii) the respective successors and assigns of any of the above, all as and to the
extent provided in this Agreement, and no other person shall acquire or have any right under or by
virtue of this Agreement. The term “successors and assigns” shall not include a purchaser of any
of the Notes from any of the several Initial Purchasers merely because of such purchase.

Section 17. Partial Unenforceability

The invalidity or unenforceability of any Section, paragraph or provision of this Agreement
shall not affect the validity or enforceability of any other Section, paragraph or provision
hereof. If any Section, paragraph or provision of this Agreement is for any reason determined to
be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such
minor changes) as are necessary to make it valid and enforceable.

Section 18. Governing Law Provisions

(a) Governing Law Provisions. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED AND
INTERPRETED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK.

(b) Consent to Jurisdiction. Any legal suit, action or proceeding arising out of or based
upon this Agreement or the transactions contemplated hereby may be instituted in the federal courts
of the United States of America located in the City and County of New York, Borough of Manhattan or
the courts of the State of New York in each case located in the City and County of New York,
Borough of Manhattan (collectively, the “Specified Courts”), and each party irrevocably submits to
the exclusive jurisdiction (except for proceedings instituted in regard to the enforcement of a
judgment of any such court, as to which such jurisdiction is non-exclusive) of such courts in any
such suit, action or proceeding. Service of any process, summons, notice or document by mail to
such party’s address set forth above shall be effective service of process for any suit, action or
other proceeding brought in any such court. The parties irrevocably and unconditionally waive any
objection to the laying of venue of any suit, action or other proceeding in the Specified Courts
and irrevocably and unconditionally waive and agree not to plead or claim in any such court that
any such suit, action or other proceeding brought in any such court has been brought in an
inconvenient forum.

Section 19. General Provisions

This Agreement constitutes the entire agreement of the parties to this Agreement and
supersedes all prior written or oral and all contemporaneous oral agreements, understandings and
negotiations with respect to the subject matter hereof. This Agreement may be executed in two or
more counterparts, each one of which shall be an original, with the same effect as if the
signatures thereto and hereto were upon the same instrument. This Agreement may not be amended or
modified unless in writing by all of the parties hereto, and no condition herein (express or
implied) may be waived unless waived in writing by each party whom the condition is meant to
benefit. The Section headings herein are for the convenience of the parties only and shall not
affect the construction or interpretation of this Agreement.

Each of the parties hereto acknowledges that it is a sophisticated business person who was
adequately represented by counsel during negotiations regarding the provisions hereof, including,
without limitation, the indemnification provisions of Section 8 and the contribution provisions of
Section 9, and is fully informed regarding said provisions. Each of the parties hereto further
acknowledges that the provisions of Sections 8 and 9 hereto fairly allocate the risks in light of
the ability of the parties to investigate the Company, its affairs and its business in order to
assure that adequate disclosure has been made in the Disclosure Package and the Final Offering
Memorandum.

2

If the foregoing is in accordance with your understanding of our agreement, kindly sign
and return to the Company and the Guarantors the enclosed copies hereof, whereupon this instrument,
along with all counterparts hereof, shall become a binding agreement in accordance with its terms.

Very truly yours,

ALASKA COMMUNICATIONS SYSTEMS

GROUP, INC.

By: /s/ David Wilson 

Name: David Wilson

Title: Senior Vice President and Chief

Financial Officer

	 	 	 
	ALASKA COMMUNICATIONS SYSTEMS	 	 
	HOLDINGS, INC.	 	ACS OF THE NORTHLAND, INC.
	By: /s/ David Wilson

	 	By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer
	ACS OF ALASKA, INC.

By: /s/ David Wilson

	 	ACS OF FAIRBANKS, INC.

By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer
	ACS OF ANCHORAGE, INC.

By: /s/ David Wilson

	 	ACS WIRELESS, INC.

By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	 	 

	 	 	 
	ACS LONG DISTANCE, INC.	 	ACS INTERNET, INC.
	By: /s/ David Wilson

	 	By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer
	ACS INFOSOURCE, INC.

By: /s/ David Wilson

	 	ACS CABLE SYSTEMS, INC.

By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer
	ACS SERVICE, INC.

By: /s/ David Wilson

	 	ACS MESSAGING, INC.

By: /s/ David Wilson
	 

	 	 
	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

	 	Name: David Wilson

Title: Senior Vice President and

Chief Financial Officer

The foregoing Purchase Agreement is hereby confirmed and accepted by the Initial Purchasers as
of the date first above written.

BANC OF AMERICA SECURITIES LLC

By: /s/ Craig Mc Cracken

Name: Craig Mc Cracken

Title: Managing Director

OPPENHEIMER & CO. INC.

By: /s/ Andrew MacInnes

Name: Andrew MacInnes

Title: Managing Director

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]